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ABSTRACT 
 
 Programmed cell death (PCD) is a fundamentally important process delicately 
coordinated throughout an organism’s life cycle. In plants, PCD is an integral part of 
development, reproduction, and pathogenesis. Numerous types of proteins are involved 
in regulation of PCD in plants, like phosphatases, metacaspases, and protein kinases. In 
tomato resistance to the pathogen Pseudomonas syringae pv. tomato (Pst), a Ser/Thr 
protein kinase, Adi3 (AvrPto-dependent Pto-interacting protein 3), interacts with the 
pathogen’s avirulence protein AvrPto and the tomato resistance protein Pto. Adi3 is a 
member of the AGC protein kinase family, a group known to transmit signals via the 
secondary messengers cAMP, cGMP, and phospholipids. In an unchallenged system, the 
master regulator of AGC kinases, Pdk1, activates Adi3. Activation of Adi3 enables 
nuclear localization and cell death suppression – all of which is prevented when 
challenged by Pst. 
 A BLASTp search of the Arabidopsis thaliania genome with the amino acid 
sequence of Adi3 identified a 67% identical match, AGC1-3. Like Adi3, AGC1-3 at its 
activation-loop serine and another site, by Pdk1. With N-terminal deletions of AGC1-3, 
Pdk1 was found to phosphorylate AGC1-3 at two serines – one serine conserved among 
all Arabidopsis AGC kinases, the other a serine on the N-terminus of the kinase domain. 
The non-activation loop serine in AGC1-3, Ser269, is conserved at Ser212, in Adi3. 
Phosphorylation at Ser212 does not impact auto-catalytic activity of Adi3. However it 
does enhance trans-catalytic activity. Analysis of AGC1-4 and AGC1-7, two proteins 
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closely related to AGC1-3, reveals that phosphorylation of non-activation loop residues 
by Pdk1 is not restricted to AGC1-3 and Adi3. Functional analysis of AGC1-3 in 
Arabidopsis protoplasts revealed that like Adi3, nuclear localization and activation-loop 
phosphorylation are essential for cell viability. 
 In an effort to elucidate a signaling network controlled by AGC1-3, the KiC 
(Kinase-client) assay was employed. In the KiC assay, a 2,100-member peptide library 
was assayed against AGC1-3 and the constitutively active mutant AGC1-3S596D. By MS 
analysis, AGC1-3 and AGC1-3S596D phosphorylated 26 and 19 substrate peptides, 
respectively. Substrate peptides were mapped to proteins involved in central metabolism, 
transcription, and protein metabolism. 
 The work presented in this dissertation provides conclusive evidence that Pdk1 
phosphorylates AGC1-3 and Adi3 at a non-activation loop residue. The work also 
supports AGC1-3 as the Arabidopsis homologue of Adi3 and presents novel 
phosphorylation data of potential AGC1-3 substrates. 
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NOMENCLATURE 
 
Adi3 AvrPto-dependent Pto-interacting protein 3 
Pdk1 3-Phosphoinositide dependent protein kinase 1 
PFP Pyrophosphate-dependent phosphofructokinase 
PFK1 Phosphofructokinase 
KiC Kinase client 
HR Hypersensitive response 
Pst Pseudomonas syringae pv. tomato 
Sl Solanum lycopersicum (Tomato)  
At Arabidopsis thaliana 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
1.1 History and significance 
1.1a Phosphorylation of proteins: 1900-1940 
 Many of the contemporary rules for protein nomenclature were agreed upon 
during a joint meeting of the American Physiological Society and the American 
Biochemical Society in 1907. Phosphoprotein was established to describe a “…protein 
molecule with some, as yet undefined, phosphorous containing substance other than a 
nucleic acid…” (Chittenden et al., 1908). Although phosphoproteins were given a 
classification, the chemical and biological relevance of phosphoproteins was unknown. 
Early experiments showed proteins were phosphorised after incubation with phosphorus 
oxychloride and dephosphorised after incubation with hydrochloric acid. Identifying 
phosphate, not inorganic phosphorus, as the molecule being added and removed from the 
protein was the key discovery from these experiments (Rimington and Kay, 1926). 
 Investigation into protein phosphorylation was an early foray into the ever-
expanding field of post-translational modifications. Many inquiries dissected the highly 
abundant milk protein  casein as their model. Phosphopeptide analysis of the trypsin 
digestion products of casein indicated that phosphate groups were covalent 
modifications of amino acids with hydroxyl groups (Rimington, 1927). Notably, the 
physical properties of solutions of phosphorylated and non-phosphorylated albumin were 
markedly different from one another. In addition to having different KOH titration 
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curves, a solution with poly-phosphorylated albumin exhibited decreased viscosity 
(Heidelberger, 1941). 
1.1b Enzymatic phosphorylation by protein kinases: 1940-1960 
By the 1940s, phosphorylation of proteins by chemical treatment had become an 
established technique and deemed essential for phosphoprotein studies. While studying 
the immunological impact of protein phosphorylation, an investigator recovered less of 
the phosphoprotein than expected and concluded that “…[enzymatic] removal of 
[phosphate] from phosphorylated proteins… could not be excluded…” (Boursnell et al., 
1948). Though it was merely speculation in the early 1940s, this idea was part of the 
basis for the entire study of reversible-protein phosphorylation. 
Ongoing studies of phosphoproteins presented two questions: how was the 
phosphate group added to the protein of interest and from whence did it originate? In 
response to the first question, a 1950 publication proposed that the addition of a 
phosphate group to a protein was only possible when that protein was in the presence of 
a phosphorylated protein (Barth and Jaeger, 1950) (Figure 1B). This publication 
suggested that phosphates are transferred from one protein to another. However, this 
proposal failed to address how the first phosphoprotein was phosphorylated. In the years 
that followed, a model for protein phosphorylation was finally proposed. An experiment 
was designed to test this new model – two substrates were utilized: radiolabeled ATP 
and highly pure casein, the enzyme was an extract from mitochondria purified from rat 
liver. At the conclusion of the experiment, a radioactive phosphate group was transferred 
from ATP to casein.   
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Figure 1. Early models of protein kinase function. A, An initial model for protein 
phosphorylation required a phosphoprotein to transfer its phosphate group to a non-
phosphorylated protein. B, A later model of protein phosphorylation consisted of ATP as 
the phosphate donor, one protein transfers a phosphate group from ATP and another 
protein receives that phosphate group. C, Reversible protein phosphorylation consists of 
a protein kinase that transfers a phosphate group from ATP to a substrate protein, 
meanwhile a protein phosphatase is responsible for dephosphorylating a phosphorylated 
protein, liberating inorganic phosphate in the process. 
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The presence of a radiolabeled phosphate on the casein indicated that the 
phosphate group must have come from the ATP, and it meant that some agent in the 
mitochondrial extract was responsible for this transfer (Burnett and Kennedy, 1954) 
(Figure 1A). In their manuscript, the authors acknowledge that although casein is 
unlikely a physiologically relevant substrate to mitochondrial protein kinases, in an in 
vitro setting it can serve as a substrate. This is because they believed that the amino acid 
sequence was responsible for determining whether or not a protein can be 
phosphorylated. The prediction that casein is phosphorylated based on its amino acid 
sequence was the initial foray into the complicated field of phosphorylation site 
prediction. 
1.1c Structure of protein kinases and processes they regulate: 1960-1990 
 The field of protein phosphorylation was still in its infancy when Edwin Krebs 
and Edmond Fischer started contributing; however by the end of their careers, Krebs and 
Fischer would be well known for their contributions to reversible protein 
phosphorylation. Krebs and Fischer joined the field in the early 1950s as junior faculty 
members at the University of Washington – the duo chose glycogen phosphorylase as 
their model to study. Phosphorylase exists in two different states – phosphorylated and 
non-phosphorylated. Krebs and Fischer’s work is summarized in a simple, yet profound 
concept that is fundamental for all young biology students - protein kinases transfer a 
phosphate from ATP and protein phosphatases remove phosphates from proteins (Figure 
1C). 
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Phosphorylation and dephosphorylation of proteins are of considerable 
importance because of their impact on fundamental biological processes. For example, 
the enzyme muscle phosphorylase fluctuates between active and inactive states, in part 
based on its phosphorylation status. Glycogen phosphorylase breaks glycogen into 
glucose 1- phosphate monomers; therefore, protein phosphorylation is related to 
carbohydrate metabolism (Newgard et al., 1989). In addition to carbohydrate 
metabolism, other metabolic processes are impacted by reversible protein 
phosphorylation. Hormone-sensitive lipase is activated by phosphorylation along with 
many other metabolism-related proteins (Krebs and Beavo, 1979). Considering that 
these fundamental processes are related to protein phosphorylation, the regulation of 
protein phosphorylation is distinctly correlated to cell health and viability.  
Since the addition of phosphate groups to proteins can alter their activity, understanding 
the protein kinases responsible for this phosphorylation is just as important as 
understanding the proteins that receive the phosphate groups. Continual studies of 
phosphorylated casein inadvertently identified which of casein’s amino acids were 
phosphorylated. The work of Claude Rimington in 1927 showed that the casein derived 
phosphopeptide his group analyzed consisted of a pair of serines, three hydroxyglutamic 
acids, and four hydroxyaminobutyric acid residues. Rimington concluded that the 
phosphate groups were on two hydroxyglutamic acid residues and a third phosphate 
molecule made a phosphodiester linkage existed between a hydroxyglutamic acid and a 
hydroxybutyric acid residue (Rimington, 1927). Continued phosphopeptide analysis only 
confirmed Rimington’s conclusion that serine was phosphorylated (Burnett and 
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Kennedy, 1954). As the field grew, other phosphorylated amino acids were identified 
and now data supports the phosphorylation of threonine, tyrosine, histidine, arginine, 
lysine, as well as glutamic and aspartic acids (Paoletti and Moss, 1972; Eckhart et al., 
1979; Huebner and Matthews, 1985; Besant et al., 2009; Attwood et al., 2011). Although 
many different variants of these amino acids have been identified, serine, threonine, and 
tyrosine are the most commonly phosphorylated residues (Figure 2). 
As of 1988, more than 100 eukaryotic protein kinases had been identified, and as 
sequencing technology improved over the years the number of annotated protein kinases 
expanded. At the time of preparation of this manuscript in the Arabidopsis thaliana 
genome, there are 1,357 loci annotated with kinase activity 
(http://www.arabidopsis.org). By the textbook definition, a protein kinase is made up of 
a catalytic domain and a regulatory domain. The catalytic domain of a protein kinase 
consists of 11 subdomains with various functions in enzyme catalysis (Hanks et al., 
1988). Of the domains, 1-5 are involved in ATP binding and the remaining subdomains 
are responsible for substrate peptide binding and transfer of the phosphate group (Hanks, 
2003) (Figure 3). 
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Figure 2. Phosphorylated amino acids. Although serine, threonine, and tyrosine are the most commonly phosphorylated 
amino acids, there are 5 other amino acids that can be phosphorylated. The hydroxyl groups of glutamate and aspartate can be 
phosphorylated, likewise phosphoramidate bonds are formed to produce phosphohistidine, phospholysine, and 
phosphoarginine. 
 
Tyrosine 
Phosphotyrosine 
Glutamate 
Phosphoglutamate Phosphoaspartate 
Aspartate Serine 
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ne 
Threonine 
Phosphothreonine 
 
Histidine 
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Phospholysine 
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Phosphoarginine 
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Figure 3. Conserved subdomains of protein kinases. The 12 conserved subdomains of 
protein kinases are defined above with the invariant residues within each subdomain. 
Subdomains 1-5 are involved ATP binding whereas subdomains 5-11 are involved in 
substrate peptide binding and phosphate transfer.
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Perception and transmission of signals is the essential role of protein kinases; 
these diverse signals include biotic and abiotic stimuli (Hanks et al., 1988). One example 
of a response to an abiotic stimulus is the phenomenon known as phototropism, the 
movement or growth of a plant toward a light source (Briggs and Christie, 2002). The 
Arabidopsis thaliana protein kinases, PHOT1 and PHOT2 mediate photoresponses by 
perception of light through chromophore-binding LOV domains (light-oxygen-voltage) 
(Briggs and Christie, 2002). The chromophore receives light energy and induces a 
conformational change in the protein, which activates the protein’s kinase activity 
(Okajima et al., 2012). The protein ATP-binding cassette B19 (ABCB19), a transporter 
of the growth hormone auxin, is one of the proteins phosphorylated by PHOT1 (Christie 
et al., 2011). Phosphorylation by PHOT1 inhibits ABCB19 transporter activity (Christie 
et al., 2011). Considering that knockout mutants of PHOT1/PHOT2 and ABCB19 do not 
exhibit the same phototropic phenotype, other substrates of PHOT1/PHOT2 are likely 
involved in the phototropism as controlled by PHOT1/PHOT2 (Briggs and Christie, 
2002; Christie et al., 2011). With an understanding of the protein kinases that perceive 
signals as well as substrates of those kinases, the signaling cascade that a plant uses to 
mediate a response to abiotic and biotic signals can be clearly defined. 
1.1d Contemporary problem – protein kinase substrates: 1990-Present 
 Kinase subdomains as described by Hanks et al. describe what constitutes a 
protein kinase, but identifying substrates of protein kinases is a different challenge. 
Protein kinases regulate a range of processes from metabolism to light signaling, and the 
proteins involved in these processes are drastically different and have different 
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sequences. In previously described experiments with rat liver mitochondria, Burnett and 
Kennedy attempted to phosphorylate casein and several other proteins, including 
lysozyme (Burnett and Kennedy, 1954). Casein, but not lysozyme, was phosphorylated 
indicating that the mitochondrial proteins discriminated between lysozyme and casein 
(Burnett and Kennedy, 1954). The discrimination between these proteins was based on 
their amino acid sequence – simply having a phosphorylatable residue does not mean 
that it will be phosphorylated. 
Identifying protein kinases can be done more readily as whole genome 
sequencing technology has advanced. Although annotation of protein kinases has 
accelerated, identifying substrates of protein kinases still relies on assays based on 
protein-protein interaction. Protein kinase substrates have dissimilar phosphorylation 
motifs – specific to the upstream kinase. Protein kinase B (PKB), also known as Akt, 
receives a great deal of attention based on its implications in cancer and other diseases. 
Many substrates of PKB have been identified, and ultimately the optimal 
phosphorylation motif for PKB was identified as RXRXX(S/T) with X indicating any 
amino acid (Obata et al., 2000). However if a protein kinases’ phosphorylation motif can 
be deduced, sequence data can be utilized to identify additional potential substrates. 
1.2 PDK1 
1.2a Structural features of PDK1 
One of the most well-studied protein kinases is the previously mentioned PKB – 
at the time of this manuscript preparation, Pubmed searches for PKB and Akt return total 
of 41,963 citations (http://www.pubmed.gov). This overwhelming amount of research is 
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in part because impaired PKB signaling in mice has been implicated in compromised 
glucose homeostasis whereas uncontrolled activation of PKB signaling leads to cancer 
(Hill and Hemmings, 2002; Calleja et al., 2007). A thorough understanding of PKB’s 
role in the cell as well as its regulation is essential for understanding numerous diseases. 
One avenue to begin that investigation is to determine how PKB is activated. Activation 
of PKB has been observed in mammalian cells treated with the hormone insulin as well 
growth factors and that activation is correlated with trans-phosphorylation of PKB at 
Thr308 and Ser473 (Alessi et al., 1997). In order to understand the activation of PKB it 
is important to understand how insulin actually is involved in the activation of PKB. 
Insulin is first perceived by the insulin receptor which upon binding insulin 
phosphorylates several of its own tyrosine residues (Czech et al., 1988). The auto-
activation of the insulin receptor enables the protein’s insulin receptor substrate-1 & -2 
to bind the insulin receptor (Alessi et al., 1997). IRS-1 and IRS-2 are phosphorylated by 
the insulin receptor and are then able to interact with a number of different proteins 
(Metz and Houghton, 2011). IRS-1 interacts with the p85 subunit of 
phosphatidylinsositol 3-kinase (PI3K), a protein which phosphorylates PtdIns(4,5)P2 
(phosphatidylinositol (4,5) diphosphate) to produce the secondary messenger 
PtdIns(3,4,5)P3 (PIP3) (Alessi et al., 1997). The production of the secondary messenger 
PIP3 is significant because it activates the protein PDK1 (3-phosphoinositol dependent 
protein kinase 1) (Metz and Houghton, 2011). Upon binding of PIP3, PDK1 activates 
PKB by phosphorylation at Thr308 (Carnero, 2010). In in vitro experiments, 
recombinant PDK1 incubated with PKB and PI(3,4,5)P3 resulted in significantly higher 
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activation of PKB than when other phospholipids were utilized like PI(3,5)P2 or 
PI(3,4)P2 (Alessi et al., 1997). The significance is that PDK1 and PKB both bind PIP3 
and are recruited to the plasma membrane where their interaction takes place (Currie et 
al., 1999; Carnero, 2010). PDK1 is known as the master regulator of AGC kinases and is 
conserved throughout many eukaryotes (Mora et al., 2004). The AGC kinase family is 
named after cAMP-dependent protein kinases, cGMP-dependent protein kinases, and 
phospholipid-dependent protein kinase C (Bogre et al., 2003). 
Binding of phospholipids by the PH domain determines subcellular localization 
of PDK1 (Currie et al., 1999). GFP fusions of wild type and a mutant PDK1, lacking the 
PH domain present different localization patterns (Currie et al., 1999). In human cells, 
the PDK1 mutant is seen throughout the cell whereas the wild type protein specifically 
localizes to the plasma membrane (PM) where many phospholipids are located (Currie et 
al., 1999). Change in localization dependent on the lipid binding by the PH domain is a 
characteristic not unique to PDK1; PKB also has a PH domain and GFP fusions of PKB 
with and without the PH domain exhibit different localization patterns (Currie et al., 
1999). Both the PH-domain mutant and wild type PKB proteins are found at the PM, 
however the concentration of the mutant at the PM is much lower (Currie et al., 1999). 
As an agonist, insulin activates the insulin receptor, which phosphorylates IRS-1, 
enabling the activation of PI3K to produce PI(3,4,5)P3 from PI(3,4)P2 (Alessi et al., 
1997). Production of PI(3,4,5)P3 facilitates the activation of PDK1 and its co-
localization with PKB (Currie et al., 1999). Understanding the control and regulation of 
this pathway continues to be an avenue for research as well as a drug target for diseases. 
  13 
PDK1 has been investigated in many different eukaryotes. In mice PDK1+/- were 
setup in mating groups and no PDK1-/- were identified, indicating that the homozygous 
mutant for PDK1 was embryonic lethal (Lawlor et al., 2002). In the budding yeast, 
Saccharomyces cerevisiae the closest homologues of mammalian PDK1, were identified 
as PKB-activating kinase homologues 1 & 2 (Pkh1 and Pkh2) (Casamayor et al., 1999). 
The Pkh1 & Pkh2 kinase domains are 72% identical to one another and are 50% 
identical to mammalian PDK1 – a noteworthy difference, however, is the absence of the 
PH domain (Casamayor et al., 1999). Analysis of Pkh1 and Pkh2 reveal proteins that are 
functionally redundant, capable of phosphorylating mammalian PKB, and are essential 
for viability (Casamayor et al., 1999). In addition to homologues of PDK1 being lethal in 
yeast and mice, the homologue in Caenorhabditis elegans appears to be developmentally 
essential. The loss-of-function mutant of C elegans PDK1 results in arrested 
development in the dauer stage, a developmental phase in which the worms do not feed 
or reproduce (Paradis et al., 1999). Given the sequence similarity and necessity for 
viability, it appears possible that PDK1 serves similarly important roles in eukaryotes. 
1.2b PDK1 interaction with substrates 
As previously mentioned, PDK1 is the master regulator of AGC kinases, a family 
of protein kinases of which PDK1 is itself a member (Pearce et al., 2010). AGC kinases 
have a diverse set of responsibilities, as previously mentioned. PKB has been implicated 
in cancer; from a molecular standpoint, one of the activities of PKB is prevention of 
caspase activation (Yamaguchi and Wang, 2001). In addition to preventing caspase 
activity, PKB regulates apoptosis by preventing the pro-apoptotic protein Bax from 
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undergoing a conformational change and subsequent transport into the mitochondria 
(Yamaguchi and Wang, 2001). Although PKB is one of the thoroughly investigated 
AGC kinases, many others have been investigated for their roles in diseases. AGC 
kinases have a number of common features, for example activation consists of 
phosphorylation within the activation loop of the protein and phosphorylation in the 
hydrophobic motif of the protein (Pearce et al., 2010). In addition to PKB, serum- and 
glucocorticoid-induced kinase (SGK) is an AGC kinase implicated in Huntington’s 
disease (Pearce et al., 2010). SGK inhibits neuronal toxicity associated with 
Huntington’s disease by phosphorylation of the Huntington’s disease protein polyQ-
huntingtin (Rangone et al., 2004). An understanding how AGC kinases are regulated as 
well as how they regulate substrates as well as the identity of those substrates can 
contribute to a greater understanding of numerous diseases. 
The structure of an AGC kinase domain consists of a pair of lobes (N- terminal 
“N” lobe and C-terminal “C” lobe) folded such that ATP is positioned by the consensus 
Mg2+ coordinating DFG motif between the lobes (Pearce et al., 2010). Phosphorylation 
of the activation loop of AGC kinases leads to conformational changes in the protein. In 
particular, phosphorylation of the activation loop of AGC kinases facilitates hydrogen 
bonding between an α-helix on the C-lobe and the N-lobe of the protein which results in 
the kinase adopting its active state (Pearce et al., 2010). 
As stated above, co-localization is important for PDK1 to interact with PKB. 
However, PKB has a PH domain enabling it to bind phospholipids and come in close 
proximity to PDK1 but not all AGC kinases have PH domains. Many of the interactions 
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between AGC kinases and PDK1 are dependent on the hydrophobic motif at the C-
terminus of the protein, known as the PIF (PDK1-interacting fragment) (Calleja et al., 
2007). The PIF is a 4-7 AA motif with a consensus sequence of FXXF(S/T)(F/Y) or 
F(D/E)XF (Biondi et al., 2000; Biondi et al., 2001; Bogre et al., 2003). In the 7 AA long 
motif, the S/T is phosphorylated or a phosphomimetic residue is present in its place 
which is their role in the 4 AA long motif (Pearce et al., 2010). Both PDK1 substrates 
S6K1 and PKB have PIF motifs. However the interaction between PDK1 and S6K1 is 
PIF dependent while the PDK1-PKB interaction is PIF-independent (Biondi et al., 2001; 
Calleja et al., 2007). In PIF-dependent interactions, the PIF of the substrate enters a 
hydrophobic pocket of PDK1 known as the PIF binding pocket (Biondi et al., 2002). The 
PIF binding pocket is in the C-lobe of PDK1 and is a 5 Å pocket formed by an alpha-
helix and a beta-sheet (Biondi et al., 2002). Within the PIF binding pocket of PDK1, the 
roles of several residues in PIF binding have been ascribed. With the human PDK1 PIF 
binding pocket as the model for PIF binding, the first two Phe of the PIF 
(FXXF(S/T)(F/Y)) bind to four pocket residues (Lys115, Ile119, Gln150, and Leu155), 
the phosphorylated Ser/Thr or acidic PIF residue (FXXF(S/T)(F/Y)) binds four pocket 
residues (Arg75, Lys76, Lys77, and Arg131), and finally the last 
Phe/Tyr(FXXF(S/T)(F/Y)) binds three pocket residues (F81, F146, and F148) (Frodin et 
al., 2002) (Figure 4A). Mutations within the PDK1 PIF binding pocket as well as 
mutations within the substrate’s PIF can impede PDK1 from interacting with its 
substrates (Balendran et al., 1999; Biondi et al., 2001). 
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A 
PDK1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN 123 
PDK1 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 161 
 
B 
PDK1 QPRKKRPEDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIK-ENKVPYV 128 
SGK1 SNPHAKPSDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILK-KKEEKHI 143 
PKB PKHRVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVA-KDEVAHT 195 
S6K1 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT 140 
    .    . *.  :::*:* :..*. .:. :       :*:*:*:*  *:   ..  :    
 
PDK1 TRERDVMSR-LDHPFFVKLYFTFQDDEKLYFGLS 161 
SGK1 MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 177 
PKB LTENRVLQN-SRHPFLTALKYSFQTHDRLCFVME 228 
S6K1 KAERNILEE-VKHPFIVDLIYAFQTGGKLYLILE 173 
   *. :: .   ***:. * ::**   :* : :.  
 
C 
Consensus  TFCGTPEYLAPE     
SGK1   TFCGTPEYLAPE 267 
PKB   TFCGTPEYLAPE 319 
S6K1   TFCGTIEYMAPE 263 
   ***** **:*** 
 
 
Figure 4. Sequence of human PDK1 PIF binding pocket. A, The PIF binding pocket 
of PDK1 is presented, residues involved in PIF binding are specified. Residues in purple 
are involved in binding the phosphorylated S/T (FxxF(S/T)(F/Y)) in the PIF, residues in 
red are involved in binding the Phe/Tyr (FxxF(S/T)(F/Y)) of the PIF, residues in orange 
are involved in binding the first two Phe (FxxF(S/T)(F/Y)) of the PIF. B, Sequences of 
the PDK1-PIF binding pocket are aligned with similar regions within SGK1, PKB, and 
S6K1. C, The consensus PDK1 phosphorylation motif is aligned with the corresponding 
sites in SGK1, PKB, and S6K1 – the first Thr in the motif is phosphorylated by PDK1.  
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Sequence alignment of PDK1 with other AGC kinases reveals conservation of 
residues within the kinase domain that constitute the PIF binding pocket (Frodin et al., 
2002) (Figure 4B). In the model for AGC kinase activation, after the PIF of a substrate 
enters the PIF binding pocket of PDK1 (Figure 5A), the substrate is phosphorylated at a 
conserved Ser/Thr within the activation loop of the protein (Belham et al., 1999) (Figure 
4C & Figure 5B). Upon trans-phosphorylation by PDK1 the substrate kinase will 
undergo a conformational change resulting in the PIF of the substrate entering the PIF 
binding pocket of the substrate (Frodin et al., 2002) (Figure 5C). After the 
conformational change has occurred and the AGC kinase’s PIF has entered it’s own PIF 
binding pocket, the kinase autophosphorylates and move on to phosphorylate substrates 
(Biondi and Nebreda, 2003) (Figure 5D). Therefore, the PIF can serve two purposes – 
first by mediating an interaction with PDK1 and by enabling autophosphorylation. 
1.2c Arabidopsis Pdk1 
PDK1 is conserved through many eukaryotes, however its essential role for 
viability varies. In Arabidopsis thaliana there are two copies of PDK1, Pdk1-1 
(At5g04510) and Pdk1-2 (At3g10540), a pair of proteins that are 92% identical (Camehl 
et al., 2011). Contrary to knockouts of the mammalian counterparts, Arabidopsis has two 
copies of Pdk1 and a double knockout of Pdk1-1 and Pdk1-2 is still viable – a notable 
phenotypic difference between the double knockout and wild type is the reduced silique 
size observed in the mutant plants (Camehl et al., 2011). An earlier investigation into 
Arabidopsis Pdk1 revealed that it was able to complement the Pkh1/Pkh2 double mutant 
(Deak et al., 1999). This analysis of Arabidopsis Pdk1 focused on Pdk1-1, 
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Figure 5. Model of AGC kinase activation by PDK1. A, the substrate AGC kinase and 
PDK1 prior to interaction, the PIF pocket of PDK1 is accessible to the substrate kinase. 
B, the PIF of the substrate kinase enters the PIF-binding pocket of PDK1 at which time 
PDK1 can phosphorylate and activate the substrate. C, the PIF of the phosphorylated 
substrate kinase folds back on itself, entering its own PIF binding pocket. D, with the 
trans-phosphorylation by PDK1, the PIF in its own PIF-binding pocket, the AGC kinase 
can auto-phosphorylate and activate itself and is capable of phosphorylating substrates of 
its own. 
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in addition to its ability to complement the pkh1Δ pkh2Δ mutant, Arabidopsis Pdk1-1 
was also able to phosphorylate mammalian PDK1 substrate PKB (Deak et al., 1999). 
Similar to its mammalian counterpart, Arabidopsis Pdk1 has a phospholipid binding PH 
domain. 
This domain binds phospholipids, and binding of phosphatidic acid and 
PtdIns(4,5)P2 activates Arabidopsis Pdk1 (Deak et al., 1999; Anthony et al., 2004). The 
presence of the PH domain and absence of one in Pkh1 and Pkh2 is interesting 
considering that Arabidopsis Pdk1 was able to complement pkh1Δ pkh2Δ with and 
without it (Deak et al., 1999). Considering that homologues of Pdk1 are essential for 
several organisms, it is likely that in Arabidopsis the substrates that it activates are 
different or at least have different functions. 
1.2d Plant AGC kinases 
 Plant AGC protein kinases are involved in a diverse array of activities – blue-
light responses, auxin transport, and root hair growth (Bogre et al., 2003). In Arabidopsis 
there are a total of 39 AGC kinases, including both isoforms of Pdk1 (Bogre et al., 
2003). The two isoforms of Pdk1 are a group separate from the others, while the 
remaining 37 are divided into 5 different groups (Bogre et al., 2003). The 37 non-Pdk1 
AGC kinases are separated based on sequence comparison to other eukaryotic protein 
kinases, these groups are designated as subfamilies AGC VI, Other, VII, VIIIb, and 
VIIIa (Bogre et al., 2003) (Figure 6A). The VIIIa and VIIIb subfamilies are subdivisions 
of the VIII family, made up of genes with highest similarity to protein kinase A (Bogre 
et al., 2003). The AGC VIII family is unique in several respects – the DFG  
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Figure 6. Phylogeny of AGC kinases in Arabidopsis and conservation of activation 
loop phosphorylation sites. A, dendrogram of Arabidopsis thaliana AGC kinases shows 
that of the 37 members of this family, not including AtPDK1-1 and AtPDK1-2, the 
largest subfamily is the VIIIa family consisting of 17 members. B, the consensus PDK1 
phosphorylation motif derived from analysis of AGC kinases in humans is highly 
conserved among AGC kinases in Arabidopsis – font color corresponds to the subfamily 
designated in 4A.
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motif found between the N and C lobes of the kinase domain is altered to DFD (Bogre et 
al., 2003). In addition to the Mg2+ coordination motif’s alteration, a unique characteristic 
of the AGC VIII kinases is an insertion of 48-109 AA within their activation loop 
(Zegzouti et al., 2006). Plant AGC kinases are involved in but not limited to 
development and reproduction, for example WAG1 and WAG2 have been implicated in 
root development by mediating auxin transport (Santner and Watson, 2006). Likewise, 
AGC1-5 and AGC1-7 have been characterized and are associated with pollen tube 
development (Zhang et al., 2009). In addition to AGC kinases from Arabidopsis, AGC 
kinases from other organisms have been studied – Adi3 from tomato is a negative 
regulator of cell death and Oxi1 from rice is a positive regulator of basal disease 
resistance (Devarenne et al., 2006; Matsui et al., 2010). 
In comparison, Arabidopsis and mammalian AGC kinases retain similar 
characteristics. The PIF motif in mammalian AGC kinases, FXXF(D/E)(F/Y) is also 
present in Arabidopsis as F(D/E)XF (Bogre et al., 2003). Similarly, the activation loop 
phosphorylation motif derived from human AGC kinases is conserved in Arabidopsis 
AGC kinases (Bogre et al., 2003) (Figure 6B). 
In addition to the conservation of the activation loop phosphorylation site and the 
presence of the PIF, several of the residues that comprise the PIF binding pocket are 
conserved as well (Figure 7). Comparison of AtPDK1-1 and mammalian PDK shows 
that the PIF binding pocket residues are highly conserved and although they are not as 
well conserved among AGC VIIIa kinases, some residues are conserved and could be 
involved in forming the PIF binding pocket (Devarenne et al., 2006). 
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AGC1-6  -GIKLGISDFRVLKRLGYGDIGSVYLVELKGANP--------TTYFAMKVMDKASLVSRN 155 
AGC1-7  -GVQLGISDFRLLKRLGYGDIGSVYLVELRGT----------ITYFAMKVMDKASLASRN 186 
AGC1-5  -GPQIGLDNFRLLKRLGYGDIGSVYLADLRGTN----------AVFAMKVMDKASLASRN 122 
AGC1-1  -HGGLGLNHFRLLKRLGCGDIGTVHLAELNGTR----------CYFAMKVMDKTALASRK 149 
AGC1-2  -HGVLGLNHFRLLKRLGCGDIGTVHLAELHGTR----------CFFAMKVMDKGALASRK 163 
AtPK5  -DGLLGLSHFRLLKRLGCGDIGSVYLSELSGTK----------CYFAMKVMDKTSLASRK 213 
Adi3  -DGILGMSHFKLLKRLGCGDIGSVYLSELSGTR----------CYFAMKVMDKASLASRK 349 
AGC1-3  -DGILGMSHFKLLKRLGCGDIGSVYLAELSGTR----------CHFAVKVMDKASLEDRK 403 
AGC1-4  -NEDLGLGHFRLLKKLGCGDIGSVYLAELREMG----------CFFAMKVMDKGMLIGRK 154 
AtPK7  -GSSLEAKDFKLIKKLGGGDIGNVYLAELIGTG----------VSFAVKVMEKAAIAARK 222 
AGC1-9  -YGSLGLRHFNLLKKLGCGDIGTVYLAELVGTN----------CLFAIKVMDNEFLARRK 599 
KIPK  -YGSLGLRHFNLLKKLGCGDIGTVYLAELIGTN----------CLFAIKVMDNEFLARRK 578 
AGC1-8  -LGSLGLRHFNLLKKLGCGDIGTVYLAELTGTN----------CLFAIKVMDNEFLERRN 581 
AGC1-10  -GRAVGLEHFRLLKRLGSGDIGSVYLCQIRGSPE--------TAFYAMKVVDKEAVAVKK 129 
PID  -KQGLTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESR-----SSYFAMKVVDKEALALKK 120 
AGC1-12  -RSSLSLSDLRFRLRLGSGDIGSVFLAEFKSLTAVTETTAVKLPLLAAKVMDKKELASRS 119 
WAG1  -DGRLHLRHFKLVRHLGTGNLGRVFLCHLRDCPN--------PTGFALKVIDRDVLT-AK 134 
WAG2  -DGNIHLRHLKLIRHLGTGNLGRVFLCNLRDSS----------ARFALKVIDRNCLTTEK 128 
PDK1  QPRKKRPEDFKFGKILGEGSFSTVVLARELATS----------REYAIKILEKRHIIKEN 123 
AtPDK1-1  -QENFTSHDFEFGKIYGVGSYSKVVRAKKKETG----------TVYALKIMDKKFITKEN 84 
          .:..    * *. . *                      * *:::.  :   .  
 
AGC1-6  KLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVME 193 
AGC1-7  KLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVME 224 
AGC1-5  KLLRAQTEREILSLLDHPFLPTLYSYFETDKFYCLVME 170 
AGC1-1  KLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVME 187 
AGC1-2  KLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVME 201 
AtPK5  KLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 251 
Adi3  KLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVME 387 
AGC1-3  KLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVME 441 
AGC1-4  KLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLME 192 
AtPK7  KLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVME 260 
AGC1-9  KTPRAQAERAILKMLDHPFLPTLYAQFTSDNLSCLVME 637 
KIPK  KSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVME 616 
AGC1-8  KMSRAQTEKDILKMLDHPFLPTLYAHFTSDNLSCLVME 619 
AGC1-10  KLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVME 167 
PID  KMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVME 158 
AGC1-12  KEGRAKTEREILESLDHPFLPTLYAAIDSPKWLCLLTE 157 
WAG1  KISHVETEAEILSLLDHPFLPTLYARIDASHYTCLLID 172 
WAG2  KLSQVETEAEILSLLDHPFLPTLYARIDESHYTCLLID 166 
PDK1  KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 161 
AtPDK1-1  KTAYVKLERIVLDQLEHPGIIKLYFTFQDTSSLYMALE 122 
  *   .  *  ::  *:**   .**  :       :  .  
 
Figure 7. Alignment of PIF binding pockets. Above is the sequences of human and Arabidopsis PDK1 PIF-binding pockets 
aligned with Arabidopsis AGC VIIIa subfamily members and the tomato AGC kinase Adi3. Residues in purple are involved in 
binding the phosphate in the PIF, residues in red are involved in binding the Phe/Tyr of the PIF, residues in orange are 
involved in binding the first two Phe of the PIF, and residues in black are mutant residues from the PDK1 reference residues. 
  23 
1.3 Tomato AGC VIIIa kinase, Adi3 
1.3a Adi3, tomato cell death regulator 
In tomatoes resistant to the bacterial pathogen Pseudomonas syringae pv. tomato, 
the host resistance protein, Pto, interacts with the avirulence protein AvrPto (Martin et 
al., 1993).The interaction between AvrPto and Pto initiates a signaling cascade resulting 
in a form of cell death known as the hypersensitive response (Morel and Dangl, 1997). 
The HR can be simply referred to as cell death development resulting from disease 
resistance and with pathogen recognition (Morel and Dangl, 1997). In a resistant plant 
upon perception of an avirulence protein, expression of multiple defense related genes 
are induced including proteins involved in biosynthesis of anti-microbial compounds 
(Morel and Dangl, 1997). To understand the signaling cascade initiated in response to a 
resistance protein interacting with an avirulence protein thoroughly, a yeast 3-hybrid 
screen was conducted to identify proteins involved in AvrPto-Pto signaling (Bogdanove 
and Martin, 2000). A total of 5 genes were identified as possibly interacting with 
AvrPto-Pto (Bogdanove and Martin, 2000). Based on interaction with AvrPto and Pto, 
these proteins were named Adi proteins – AvrPto dependent Pto interacting protein 
(Bogdanove and Martin, 2000). Virus induced gene silencing (VIGS) of one of the 
candidate genes, Adi3, resulted in development of cell death lesions throughout tomato 
leaves (Devarenne et al., 2006). Further characterization of this protein identified it as a 
Ser/Thr protein kinase and in particular, a member of the AGC VIIIa family of protein 
kinases (Devarenne et al., 2006). The investigation of Adi3 as a cell death regulator 
directed studies in multiple directions. First, an investigation was undertaken to identify 
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what components of Adi3 alter cell viability, followed by an investigation into what 
signaling partners Adi3 utilizes by using a yeast 2-hybrid screen of a cDNA library (Ek-
Ramos et al., 2010; Avila et al., 2012).1.3b Adi3 localization and cell viability 
Adi3, like other AGC VIIIa family members has a large insertion within its 
activation loop – 74 AA in the case of Adi3 (Devarenne et al., 2006). An Adi3 mutant 
with the activation loop extension deleted did not alter auto- or trans-catalytic activity of 
Adi3, the interaction with PDK1, or its ability to phosphorylate Adi3 (Ek-Ramos et al., 
2010). However, transient expression of the Adi3 activation-loop extension mutant 
resulted in decreased cell viability indicating that the activation-loop extension was 
fundamentally important for cell viability (Ek-Ramos et al., 2010). After looking at the 
activation-loop extension sequence it was determined that a nuclear localization signal 
(504PQKSKKK510) was in that region of the protein (Ek-Ramos et al., 2010). Microscopy 
and cell viability studies revealed that two factors were important and inseparable for 
Adi3 – nuclear localization and phosphorylation at the activation loop serine (Ek-Ramos 
et al., 2010). Mutants of Adi3 that cannot be phosphorylated at the activation loop serine 
and lacked the activation loop extension reduced cell viability to ~20% of wild type (Ek-
Ramos et al., 2010). Microscopy studies revealed that this same mutant did not localize 
to the nucleus like its wild type counterpart (Ek-Ramos et al., 2010). A strong correlation 
exists between nuclear localization, activation loop phosphorylation, and cell viability as 
well as nuclear localization. 
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1.3c Adi3 signal transduction 
The investigation into signaling partners of Adi3 identified SnRK as an 
interacting partner (Avila et al., 2012). SnRK is a α-subunit of the SnRK1 complex, 
which is homologous to sucrose nonfermenting 1 (Snf1) in yeast and AMP-activated 
protein kinase (AMPK) in mammals. In yeast, Snf1 was first studied in the context of 
mutants which were unable to metabolize sucrose, galactose, or maltose (Celenza and 
Carlson, 1986). In mammals, the AMPK complex can regulate metabolism by induction 
of fatty acid oxidation in order to produce more ATP in demanding scenarios (Luo et al., 
2010). This complex is conserved as a heterotrimer made up of a catalytic β-subunit and 
two regulatory subunits – α and ϒ (Luo et al., 2010). Although Adi3 was found to 
interact with the regulatory α-subunit, SnRK, it was determined that Adi3 was able to 
phosphorylate the catalytic β-subunit GAL83, both in vivo and in in vitro kinase assays 
(Avila et al., 2012). Phosphorylation of the β-subunit by Adi3 reduces SnRK1 complex 
kinase activity (Avila et al., 2012). Ultimately Adi3 is a cell death suppressor requiring 
nuclear localization and activation loop phosphorylation, how Adi3’s phosphorylation of 
the SnRK1 complex relates to cell death remains to be fully understood.  
1.4 Protein kinase substrate identification techniques 
 Identifying interacting partners of protein kinases is critical to understand how a 
stimulus is transmitted. For example, understanding the regulation of the signaling 
cascade that flows through PHOT1 and PHOT2 will provide a thorough understanding 
of the processes activated and/or inhibited that result in a phototropic response (Briggs 
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and Christie, 2002). In some cases interacting partners are identified through genetic 
analysis using mutant plants (Christie et al., 2011). 
An inherent challenge in identifying substrates of a protein kinase is that the 
interaction between a kinase and its substrate is expected to be transient in many cases 
(Ptacek et al., 2005). A successful and commonly employed method of identifying 
substrates and interacting partners is the yeast 2-hybrid assay – as previously mentioned, 
a yeast 2-hybrid screen was employed using Adi3 to identify SnRK as an interacting 
partner (Avila et al., 2012). The yeast 2-hybrid assay is not the only technique to employ 
a library-based approach; phage display is another technique that has successfully 
identified interacting partners of protein kinases (Watson et al., 1999). Phage display and 
the yeast 2-hybrid system both potentially identify interacting partners that are not 
necessarily substrates so if a substrate is the project goal, these techniques might not 
provide the desired data.  
 To identify substrates rather than interacting partners, the kinase of interest is 
mutated to use “bulky” ATP analogs, which also have a radiolabel or sulfur on the ϒ-
phosphate, which is then chemically modified and detected specifically by an anti-body 
(Koch and Hauf, 2010; Dittrich and Devarenne, 2012). A developing technique is to use 
proteins printed on a plate much like a microarray, incubate the plate with a kinase and 
radiolabeled ATP and based on the position of the radiolabel on the plate, a potential 
substrate peptide can be determined (MacBeath and Schreiber, 2000). 
 In addition to experimental techniques, bioinformatics substrate prediction tools 
have been developed in part a result of the increasing volume of interaction and 
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phosphorylation data available (Lai et al., 2012). The fundamental issue is that predicted 
substrates still must be confirmed experimentally. However it does provide a starting 
point for investigation of a signaling network. 
 Although all of these approaches have drawbacks they can provide some insight 
into what processes a protein kinase can activate or inhibit and what processes are 
altered by a given stimulus. 
1.5 Dissertation overview 
 The work detailed in this dissertation was conducted to begin the characterization 
of the Arabidopsis thaliana homologue of the tomato cell death suppressing protein, 
Adi3. I begin this work by investigating the non-activation loop phosphorylation site of 
AGC1-3 and Adi3. In work conducted with fellow lab members, we determined that the 
second phosphorylation site of AGC1-3 was conserved within Adi3. Additionally, this 
second phosphorylation site proved valuable to activation of the Adi3 substrate GAL83. 
I followed that work up by investigating if other AGC VIIIa protein kinases have 
additional, non-activation loop phosphorylation sites. The last portion of my dissertation 
investigates substrates of AGC1-3 in an effort to expand this project in Arabidopsis as 
well as with Adi3, by identifying potential substrates using the Kinase Client assay. 
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CHAPTER II 
METHODS* 
2.1 Cloning and site directed mutagenesis 
Cloning of the Adi3, SlPdk1, and Gal83 cDNAs into pMAL-c2 and 
expression/purification of protein from Escherichia coli for N-terminal maltose binding 
protein (MBP) translational fusions were previously described (Devarenne et al., 2006; 
Avila et al., 2012). Site-directed mutagenesis was carried out using standard protocols 
and Pfu Turbo DNA polymerase (Stratagene). All primers used in this study for cloning 
and mutagenesis are listed in Table 1. The Arabidopsis thaliana sequence homolog to 
Adi3, AGC1-3 (At2g44830; accession # AY078927), was identified by BLAST of the 
Arabidopsis genome (www.arabidopsis.org) using the full-length open reading frame 
(ORF) sequence of Adi3. The 2298 bp full-length ORF of AGC1-3 was cloned by RT-
PCR. Total mRNA was extracted from Arabidopsis (Col-0) leaf tissue and first strand 
synthesis was completed with the SuperScriptII cDNA synthesis kit (Invitrogen). The 
AGC1-3 ORF was amplified from first strand cDNA with primers based at the ATG 
start codon and the TAA stop codon using GoTaq Green (Promega). The product was 
cloned into pCR2.1-TOPO (Invitrogen) to confirm identity by sequencing. All AGC1-3 
variants (full-length and N-terminal deletions) were cloned into a modified form of  
                                                 
* Portions of the following article have been reprinted with permission from: Gray J, 
Nelson Dittrich AC, Chen S, Avila J, Giavalisco P, Devarenne TP (2013) Two Pdk1 
phosphorylation sites on the plant cell death suppressor Adi3 contribute to substrate 
phosphorylation. Biochim Biophys Acta 1834: 1099-1106. Copyright 2013 © by 
Elsevier. 
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Table 1. Primers used in this study. 
Gene Primer Name Purpose Direction Restriction site Sequence 
AGC1-3 AtAdi3 1.2F Amplifying ORF from first 
strand synthesis 
Forward  ATGCTGGAAATGGAAAGAG 
 
AGC1-3 AtAdi3-2298R Amplifying ORF from first 
strand synthesis 
Reverse  TTAGAAAAACTCAAAGTCTAGAAAT
TTA 
CCACCAGATTTCGTGTCTGCTGCTG
CTGC 
 
AGC1-3 AGC1-3/1-
EcoRIF 
Amplifying ORF for 
pEG202/pJG4-5 
Forward EcoRI CACGAATTCATGCTGGAAATGGAAA
GAG 
 
AGC1-3 AGC1-3/2298-
XhoIR 
Amplifying ORF for 
pEG202/pJG4-5 
Reverse XhoI CACCTCGAGTTAGAAAAACTCAAAG
TC 
AtPDK1-1 AtPDK1-1/1-
EcoRIF 
Amplifying ORF for 
pEG202/pJG4-
5/pGEX/pETMAL 
Forward EcoRI CACGAATTCATGTTGGCAATGGAG 
AtPDK1-1 AtPDK1-1/1476-
XhoIR 
Amplifying ORF for 
pEG202/pJG4-
5/pGEX/pETMAL 
Reverse XhoI CACCTCGAGTCAGCGGTTCTGAAGA
GT 
 
MBP MBP/NdeI Amplifying ORF for pETMAL 
construction 
Forward NdeI CACCATATGAAAACTGAAGAAGGT 
MBP MBP/SpeI Amplifying ORF for pETMAL 
construction 
Reverse SpeI CACACTAGTTGAAATCCTTCCCTC 
 
AtPDK1-1 K73QF Mutagenesis Forward  ACTGTGTATGCTTTACAGATTATGG
ACAAAAAG 
AtPDK1-1 K73QR Mutagenesis Reverse  CTTTTTGTCCATAATCTGTAAAGCAT
ACACAGT 
AGC1-3 BamHI/HA/AGC
1-3F 
Amplifying ORF for pGEX Forward BamHI CACGGATCCATGTATCCCTACGACG
TCCCCGATTATGCACTGGAAATGGA
A 
AGC1-3 AGC1-3/2298-
SalIR 
Amplifying ORF for pGEX Reverse SalI CACGTCGACTTAGAAAAACTCAAAG
TC 
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Table 1. Continued. 
AGC1-3 AGC1-3 K392QF Mutagenesis Forward  CGATGCCATTTTGCTGTGCAAGTCA
TGGATAAAGCGTCT 
AGC1-3 AGC1-3 
K392QR 
Mutagenesis Reverse  AGACGCTTTATCCATGACTTGCACA
GCAAAATGGCATCG 
AGC1-3 AGC1-3 S596AF Mutagenesis  Forward  CCTAACACACGGTCCATGGCCTTTG
TTGGAACCCACGAG 
AGC1-3 AGC1-3 S596AR Mutagenesis Reverse  CTCGTGGGTTCCAACAAAGGCCATG
GACCGTGTGTTAGG 
AGC1-3 AGC1-3 S596DF Mutagenesis Forward  CCTAACACACGGTCCATGGACTTTG
TTGGAACCCACGAG 
AGC1-3 AGC1-3 S596DR Mutagenesis Reverse  CTCGTGGGTTCCAACAAAGTCCATG
GACCGTGTGTTAGG 
AGC1-3 AGC1-3 K562AF Mutagenesis Forward  AGCATCTTCCCTAACGCAAACAAAA
AAAACAAG 
AGC1-3 AGC1-3 
K562AR 
Mutagenesis Reverse  CTTGTTTTTTTTGTTTGCGTTAGGGA
AGATGCT 
AGC1-3 AGC1-3 K565AF Mutagenesis Forward  CCTAACGCAAACAAAGCAAACAAG
TCCCGTAAA 
AGC1-3 AGC1-3 
K565AR 
Mutagenesis Reverse  TTTACGGGACTTGTTTGCTTTGTTTG
CGTTAGG 
AGC1-3 d100 AGC1-3 
EcoRI 
Amplifying N-terminal 100AA 
deletion of AGC1-3 for 
pETMAL 
Forward EcoRI CACGAATTCATGAGAACGATGAAG
GCC 
AGC1-3 d200 AGC1-3 
EcoRI 
Amplifying N-terminal 200AA 
deletion of AGC1-3 for 
pETMAL 
Forward EcoRI CACGAATTCATGCTTTCACCTGCAG
AAAGC 
AGC1-3 d300 AGC1-3 
EcoRI 
Amplifying N-terminal 300AA 
deletion of AGC1-3 for 
pETMAL 
Forward EcoRI CACGAATTCATGGTTTTGGATTCGT
TT 
AGC1-3 d400 AGC1-3 
EcoRI 
Amplifying N-terminal 400AA 
deletion of AGC1-3 for 
pETMAL 
Forward EcoRI CACGAATTCATGGACCGGAAGAAG
TTG 
 
AGC1-3 d225 AGC1-3 
EcoRI 
Amplifying N-terminal 225AA 
deletion of AGC1-3 for 
pETMAL 
Forward EcoRI CACGAATTCATGAACACTGAAAACT
CT 
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Table 1. Continued. 
AGC1-3 d250 AGC1-3 
EcoRI 
Amplifying N-terminal 250AA 
deletion of AGC1-3 for 
pETMAL 
Forward EcoRI CACGAATTCATGAATGTGAGCCCAC
AT 
AGC1-3 d275 AGC1-3 
EcoRI 
Amplifying N-terminal 275AA 
deletion of AGC1-3 for 
pETMAL 
Forward EcoRI CACGAATTCATGGCAACAAGTACTA
CT 
AGC1-3 dPIF AGC1-3 
XhoI 
Amplifying AGC1-3 without the 
C-terminal PIF 
Reverse XhoI CACCTCGAGTTAGTCTAGAAATTTAC
C 
AGC1-3 AGC1-3 S253AF Mutagenesis Forward  CCCAGTACCAATGTGGCCCCACATAG
CAGTAGT 
AGC1-3 AGC1-3 S253AR Mutagenesis Reverse  ACTACTGCTATGTGGGGCCACATTGG
TACTGGG 
AGC1-3 AGC1-3 S261AF Mutagenesis Forward  AGCAGTAGTGTTGAAGCCATGAATTT
GGCTCGG 
AGC1-3 AGC1-3 S261AR Mutagenesis Reverse  CCGAGCCAAATTCATGGCTTCAACAC
TACTGCT 
AGC1-3 AGC1-3 S269AF Mutagenesis Forward  TTGGCTCGGGCTATGGCCATTGCTAA
TAGCTCT 
AGC1-3 AGC1-3 S269AR Mutagenesis Reverse  AGAGCTATTAGCAATGGCCATAGCC
CGAGCCAA 
AGC1-4 5’ At5g40030 
cDNA 
Amplifying ORF from first 
strand synthesis 
Forward  ATGAGTAAACAAACTCCAAATCTTG
AA 
AGC1-4 3’ At5g40030 Amplifying ORF from first 
strand synthesis 
Reverse  CTAGAAGAACTCAAAATCTAAATAA
GG 
AGC1-4 AGC1-4 EcoRI Amplifying ORF for pGEX Forward EcoRI ACGAATTCATGAGTAAACAAACTCC
AAAT 
AGC1-4 AGC1-4 XhoI Amplifying ORF for pGEX Reverse XhoI ACCTCGAGCTAGAAGAACTCAAAAT
C 
AGC1-4 AGC1-4 K143QF Mutagenesis Forward  CTTTGCTATGCAAGTGATGGATAAA 
AGC1-4 AGC1-4 
K143QR 
Mutagenesis Reverse  CATTCCTTTATCCATCACTTTCATAGC 
AGC1-4 AGC1-4 S343AF Mutagenesis Forward  ATGCGTGCCAACGAATGCCATAGAT
CGAGC 
AGC1-4 AGC1-4 S343AR Mutagenesis Reverse  GCTCGATCTATGGCATTCGTTGGCAC
GCAT 
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Table 1. Continued. 
AGC1-7 AGC1-7 EcoRI Amplifying ORF for pGEX Forward EcoRI ACGAATTCATGTTAACGAAGCCCGG
AAAG 
AGC1-7 AGC1-7 XhoI Amplifying ORF for pGEX Reverse XhoI ACCTCGAGCTAAAAGTATTCAAAGTC 
AGC1-7 AGC1-7 K175QF Mutagenesis Forward  ACCTATTTCGCCATGCAAGTGATGGA
CAAGGCT 
AGC1-7 AGC1-7 
K175QR 
Mutagenesis Reverse  AGCCTTGTCCATCACTTGCATGGCGA
AATAGGT 
AGC1-7 AGC1-7 S379AF Mutagenesis Forward  AACGTTAAGTCAATGGCATTCGTTGG
AACACAC 
AGC1-7 AGC1-7 S379AR Mutagenesis Reverse  GTGTGTTCCAACGAATGCCATTGACT
TAACGTT 
PFP PFP EcoRI Amplifying ORF for pGEX Forward EcoRI CACGAATTCATGGCCCCTGCTCTCGC
C 
PFP PFP XhoI Amplifying ORF for pGEX Reverse XhoI GTGCTCGAGCTATTGAGCCCCGAGTT
C 
PFP PFP T008AF Mutagenesis Forward  CCTGCTCTCGCCGTTGCGCGAGATCT
CACCGCC 
PFP PFP T008AR Mutagenesis Reverse  GGCGGTGAGATCTCGCGCAACGGCG
AGAGCAGG 
PFP PFP T012AF Mutagenesis Forward  GTTACACGAGATCTCGCCGCCGTCGG
ATCTCCG 
PFP PFP T012AR Mutagenesis Reverse  CGGAGATCCGACGGCGGCGAGATCT
CGTGTAAC 
PFP PFP 
T008A/T012AF 
Mutagenesis Forward  GTTGCGCGAGATCTCGCCGCCGTCGG
ATCTCCG 
PFP PFP 
T008A/T012AR 
Mutagenesis Reverse  CGGAGATCCGACGGCGGCGAGATCT
CGCGCAAC 
PFP PFP T008DF Mutagenesis Forward  CCTGCTCTCGCCGTTGACCGAGATCT
CACCGCC 
PFP PFP T008DR Mutagenesis Reverse  GGCGGTGAGATCTCGGTCAACGGCG
AGAGCAGG 
PFP PFP T012DF Mutagenesis Forward  GTTACACGAGATCTCGACGCCGTCGG
ATCTCCG 
PFP PFP T012DR Mutagenesis Reverse  CGGAGATCCGACGGCGTCGAGATCT
CGTGTAAC 
PFP PFP 
T008D/T012DF 
Mutagenesis Forward  GTTGACCGAGATCTCGACGCCGTCGG
ATCTCCG 
PFP PFP 
T008D/T012DR 
Mutagenesis Reverse  GTTGACCGAGATCTCGACGCCGTCGG
ATCTCCG 
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Table 1. Continued. 
Adi3 S119A Mutagenesis Forward  CTGGTGAAAAACGTAGCATTGAAGGGT
CCTTTC 
Adi3 S119A Mutagenesis Reverse  GAAAGGACCCTTCAATGCTACGTTTT
TCACCAG 
Adi3 S119D Mutagenesis Forward  CTGGTGAAAAACGTAGACTTGAAGG
GTCCTTTC 
Adi3 S119D Mutagenesis Reverse  GAAAGGACCCTTCAAGTCTACGTTTT
TCACCAG 
Adi3 S212A Mutagenesis Forward  GTTGTGAGATCTATGGCAATTGTCAA
CAGTTGC 
Adi3 S212D Mutagenesis Reverse  GCAACTGTTGACAATTGCCATAGATC
TCACAAC 
Adi3 S518A Mutagenesis Forward  GTTGTGAGATCTATGGACATTGTCAA
CAGTTGC 
Adi3 S518A Mutagenesis Reverse  GCAACTGTTGACAATGTCCATAGATC
TCACAAC 
Adi3 S518D Mutagenesis Forward  CCTAAGCCTCGAGCTGATGCAGGGTT
TCAAGCTAATTCAATGCC 
Adi3 S518D Mutagenesis Reverse  GGCATTGAATTAGCTTGAAACCCTGC
ATCAGCTCGAGGCTTAGG 
Adi3 S651A Mutagenesis Forward  GCTCTAATACGTTGCGCAACACCACC
TGAAGTG 
Adi3 S651A Mutagenesis Reverse  CACTTCAGGTGGTGTTGCGCAACGTA
TTAGAGC 
Adi3 S651D Mutagenesis Forward  GCTCTAATACGTTGCGATACACCACC
TGAAGTG 
Adi3 S651D Mutagenesis Reverse  CACTTCAGGTGGTGTATCGCAACGTA
TTAGAGC 
Adi3 S680A Mutagenesis Forward  GGGGTTGGCAATACCGCAAAAAGAG
TGGTAGGG 
Adi3 S680A Mutagenesis Reverse  CCCTACCACTCTTTTTGCGGTATTGC
CAACCCC 
Adi3 S680D Mutagenesis Forward  GGGGTTGGCAATACCGACAAAAGAG
TGGTAGGG 
Adi3 S680D Mutagenesis Reverse  CCCTACCACTCTTTTGTCGGTATTGC
CAACCCC 
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pET41a (Novagen), which expresses MBP-fusions rather than GST-fusion proteins. This 
modified pET41a was created by digestion with NdeI and SpeI to remove the GST ORF 
and cloning of the MBP ORF, amplified from pMAL-C2, into the same sites. Expression 
and purification of MBP-AGC1-3 fusion proteins expressed from the modified pET41a 
yielded higher protein levels compared to pMAL-C2, possibly due to the longer linker 
region between MBP and AGC1-3 in the modified pET41a compared to pMAL-C2. All 
variants of AGC1-3 used in this study were cloned into the 5′ EcoRI and 3′ XhoI sites of 
the modified pET41a vector, and the yeast 2-hybrid plasmids pEG202 and pJG4-5. For 
localization and cell viability studies, AGC1-3 was cloned in frame into the BamHI and 
SalI sites of pTEX-eGFP (Ek-Ramos et al., 2010), producing an N-terminal fusion of 
GFP. 
 The full-length AGC1-4 (At5g40030; accession # NM 123366) ORF was 
amplified from first strand synthesis product made from a total mRNA extract, just as 
AGC1-3. After sequencing, AGC1-4 was amplified and cloned into the EcoRI and XhoI 
sites of the bacterial expression vector pGEX (Amersham Biosciences). 
The AtPdk1-1 cDNA (At5g04510; accession # NM_203001) has been previously 
described (Deak et al., 1999). The full length AtPdk1-1 ORF was amplified from first 
strand cDNA and cloned into pCR2.1-TOPO as with AGC1-3. The AtPdk1-1 ORF was 
subcloned into the EcoRI and XhoI sites of the bacterial expression vectors pGEX and 
pMAL-c2, and the yeast 2-hybrid plasmids pEG202 & pJG4-5. 
 Full-length cDNA clones of AGC1-7 (At1g79250; # NM 106575), PFP 
(pyrophosphate dependent PFK1) (At1g12000; accession # NM_101072), and AMP 
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deaminase (At2g38280; accession # NM_129384) were procured from the ABRC 
(Arabidopsis Biological Research Center) in the plant expression vector pUNI51. Full-
length cDNAs of AGC1-7 and PFP were amplified and cloned into the EcoRI and XhoI 
sites of the pGEX expression plasmid. Full-length AMP deaminase was cloned into the 
MBP expression vector pETMAL. 
2.2 Mass spectrometry 
For MS analysis of Adi3 phosphorylation sites, 5 μg of MBP-Adi3 was 
phosphorylated by 1 μg MBP-Pdk1 in an in vitro kinase assay and samples separated by 
10% SDS-PAGE as detailed below for kinase assays, except non-radiolabeled ATP was 
used. For sample preparation, coomassie stained gel bands were in-gel digested with 
trypsin overnight (Sheffield et al., 2006) and phosphopeptides were enriched using a 
NuTip metal oxide phosphoprotein enrichment kit according to manufacturer's 
instructions (Glygen, Columbia, MD). 
For LC–MS/MS analysis, phosphopeptides were injected onto a capillary trap 
(LC Packings PepMap, Amsterdam, Netherlands) and desalted for 5 min with 0.1% v/v 
acetic acid at a flow rate of 3 μl/min. The samples were loaded onto an LC Packings 
C18 PepMap nanoflow HPLC column. The elution gradient of the HPLC column started 
at 97% solvent A, 3% solvent B and finished at 60% solvent A, 40% solvent B for 
30 min. Solvent A consisted of 0.1% v/v acetic acid, 3% v/v ACN, and 96.9% v/v H2O. 
Solvent B consisted of 0.1% v/v acetic acid, 96.9% v/v ACN, and 3% v/v H2O. LC–
MS/MS analysis was carried out on a LTQ Orbitrap XL mass spectrometer (Thermo 
Scientific, Bremen, Germany). The instrument under Xcalibur 2.07 with LTQ Orbitrap 
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Tune Plus 2.55 software was operated in the data dependent mode to automatically 
switch between MS and MS/MS acquisition. Survey scan MS spectra (from m/z 300–
2000) were acquired in the orbitrap with resolution R = 60,000 at m/z 400. During 
collisionally induced dissociation (CID), if a phosphate neutral loss of 98, 49, 32.66 and 
24.5 m/z below the precursor ion mass was detected, there was an additional activation 
of all four neutral loss m/z values. This multistage activation was repeated for the top 
five ions in a data-dependent manner. Dynamic exclusion was set to 60 s. Typical mass 
spectrometric conditions include a spray voltage of 2.2 kV, no sheath and auxiliary gas 
flow, a heated capillary temperature of 200 °C, a capillary voltage of 44 V, a tube lens 
voltage of 165 V, an ion isolation width of 1.0 m/z, and a normalized CID collision 
energy of 35% for MS/MS in LTQ. The ion selection threshold was 500 counts for 
MS/MS. The mass spectrometer calibration was performed according to the 
manufacturer's guidelines using a mixture of sodium dodecyl sulphate, sodium 
taurocholate, MRFA and Ultramark. 
 For the protein search algorithm, all MS/MS spectra were analyzed using Mascot 
(Matrix Science, London, UK; version 2.4). Mascot was set up to search a 
current Arabidopsis database assuming the digestion enzyme trypsin and one 
miscleavage. Mascot was searched with a fragment ion mass tolerance of 0.80 Da and a 
parent ion tolerance of 10 ppm. Iodoacetamide derivative of Cys, deamidation of Asn  
and Gln, oxidation of Met and phosphorylation of serine, threonine and tyrosine are 
specified as variable modifications. The MS/MS spectra of the identified phosphorylated 
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peptides were manually inspected to ensure confidence in phosphorylation site 
assignment. 
2.3 Yeast two-hybrid assays 
 Y2H assays were conducted using pEG202 for the bait vector and pJG4-5 for the 
prey vector as described previously (Devarenne et al., 2006). Constructs were 
transformed into yeast strain EGY48 containing the pSH18-34 reporter vector and 
analyzed for LacZ gene expression on 5-bromo-4-chloro-3-indolyl-β-D- 
galactopyranoside-containing plates. Protein expression was confirmed by Western blot. 
All other procedures for the Y2H assays followed standard procedures as described 
previously (Golemis et al., 2008). 
2.4 Recombinant protein expression and purification 
For the purpose of protein purification, cells were grown in 400mL cultures of 
TB at 37° with shaking to an OD600 = 0.5-0.7. Protein expression was induced with 
100uM IPTG isopropyl β-D-1-thiogalactopyranoside (IPTG) for 5 hours at 25°. Cultures 
were spun down at 4,000xg for 10 minutes. Cell pellets were stored at -20° until they 
were prepared for protein purification. 
MBP fusions were resuspended in EB1 (50mM Tris, pH 8.0, 50mM NaCl, 5mM 
EDTA, 1% Triton X-100) volume equal to 10% of the original culture volume. GST 
fusion proteins were resuspended in EB2 (1X PBS, 1% Triton X-100) volume equal of 
10% of the original culture volume. Resuspended protein extracts were sonicated 3 times 
for 30 seconds, at power setting of 10, at one-minute intervals. The sonicated samples 
were centrifuged at 10,000xg for 20 minutes at 4°. 
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 EB1 or EB2 was added to the protein lysate to a total volume of 200mL and then 
loaded onto either a GST-Trap or MBP-Trap column. The protein was flowed over the 
affinity column at flow rate of 0.2mL/min using the Akta Prime FPLC System (GE 
Healthcare Life Sciences). The lysate was flowed over the column for a total of 500mL 
and then washed with 15 column volumes of the respective extraction buffer. After 
washing the column with 15 CV of extraction buffer, the column was washed with 25 
CV with EB3 (50mM Tris, pH 8.0, 50mM NaCl, 5mM EDTA). MBP fusion proteins 
were eluted with EB3 with 100mM maltose (Fluka) and GST fusion proteins were eluted 
with EB3 supplemented with 10mM glutathione (Sigma-Aldrich). Eluted proteins were 
collected in 1.2mL fractions and analyzed by SDS-PAGE to identify fractions containing 
protein. Fractions containing protein were pooled, concentrated, and stored as 20% 
glycerol stocks. 
2.5 Pulldown assays 
For MBP-AGC1-3 and GST-AtPdk1-1 pull-down assays, cell pellets from 2 ml 
cultures were lysed by sonication in 500 μl of extraction buffer (50 mM Tris, pH 8.0, 
50 mM NaCl, 5 mM EDTA, 0.1% Triton X-100, 1 × general protease inhibitors 
[Sigma]) and cell debris pelleted by centrifugation at 5000 ×g, 4 °C for 5 min. One 
hundred μg of the supernatant (total protein) from each extract was added to 50 μl of 
equilibrated amylose resin, the volume was adjusted to 1 ml with extraction buffer, 
incubated on a nutator at 4 °C for 30 min, the resin was pelleted by centrifugation at 
1000 ×g for 1 min, and the resin was washed 3 times with 500 μl of extraction buffer. 
Samples were eluted from the resin with 100 μl of 1 × SDS-PAGE buffer at 95 °C for 
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5 min, and 5 μl of each sample was analyzed by 10% SDS-PAGE. Proteins were 
analyzed by Western blotting using α-GST (Santa Cruz Biotechnology) at 1:4000 or α-
MBP (New England BioLabs) at 1:10,000. 
2.6 Kinase assays 
 In vitro kinase assays were done in 30 μl reactions in kinase buffer (10 mM Tris–
HCl, pH 7.5, 10 mM MgCl2, 1 mM dithiothreitol [DTT]) with the protein amounts given 
in the figure legends. The reactions were started by the addition of 0.25 μCi of [γ-
32P]ATP (6000 Ci mmol− 1; Perkin-Elmer) and non-radiolabeled ATP to a final 
concentration of 20 μM per sample followed by incubation for 30 min at 30 °C. 
Reactions were terminated by the addition of 4 × SDS-PAGE sample buffer, and 
samples were resolved by 10% SDS-PAGE or 1:200 bis-acrylamide:acrylamide 10% 
SDS-PAGE. Visualization and quantification of incorporated radioactivity were done 
using a phosphorimager (Bio-Rad Molecular Imager) and quantification software (Bio-
Rad Quantity One). For non-radioactive kinase assays, the assays were carried out as 
above with the omission of [γ-32P]ATP. The kinase artificial substrate myelin basic 
protein was purchased from Sigma. 
2.7 1:200 bis-acrylamide SDS-PAGE 
 10% SDS-PAGE gels with a 1:200 bis-acrylamide:acrylamide ratio were made 
by mixing the following: 2.5 ml 4 × resolving gel buffer (1.5 M Tris-base, 0.4% SDS, 
pH 8.8), 3.317 ml 30% acrylamide, 250 μl 2% bis-acrylamide, 50 μl 10% ammonium 
persulfate, and 5 μl N, N, N′, N′-tetramethylethylenediamine (TEMED) in a final volume 
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of 10 ml. These gels were used with a typical 4% acrylamide stacking gel. Gels were run 
at 150V for approximately 4h. 
2.8 λ Phosphatase treatment 
 Adi3 and SlPdk1 were incubated in a 30 μl in vitro kinase assay as described 
above with only non-radiolabeled ATP. Following the kinase assay 4 μl of 10× λ 
phosphatase buffer (500mM HEPES, pH 7.5, 1M NaCl, 20mM DTT, 0.1% Brij 35) and 
4μl of 10mM MnCl2 were added for a final volume of 38 μl. Reactions were started with 
the addition of 800units (2 μl) of λ phosphatase (New England Biolabs), incubated at 
30 C for 1h, and reactions were terminated by the addition of 10 μl 4× SDS-PAGE 
sample buffer. Samples were then resolved by 1:200 bis-acrylamide:acrylamide 10% 
SDS-PAGE as described above. 
2.9 Protoplast protein expression and cell death assays 
 Wild type Arabidopsis (Col-0) were grown under an 16 hour light schedule at 
~23° C for ~4-5 weeks, rosette leaves were cut off before bolting occurred and digestion 
of leaves was done as previously reported, with slight modifications (Yoo et al., 2007). 
Leaf strips were incubated in the enzyme solution (Xing et al., 2001) in the dark for no 
more than 16 hours and no less than 12 hours. A slightly different enzyme solution was 
used to facilitate effective separation of viable from dead protoplasts (see below). After 
digestion, the enzyme-protoplasts solution was filtered through a metal sieve, separating 
liberated protoplasts from undigested leaf tissue. The liberated protoplasts were collected 
in a 15mL round bottom Falcon tube and centrifuged with an overlay of 1mL of W5 
solution (125mM CaCl2, 5mM glucose, 5mM KCl, 1.5mM MES, 154mM NaCl) at 
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100xg for 3 minutes this step separates viable protoplasts from dead cells and extraneous 
debris. This W5 overlay step is the only modification to the protocol for Arabidopsis 
protoplast recovery (Yoo et al., 2007). Prior to transformation, cells were counted with a 
hemacytometer and concentration was adjusted to 1x105 cells/mL. Transformations 
consisted of 200μL of protoplasts (4x104 cells), 20% PEG solution was used, and 25μg 
of each pTEX-eGFP plasmid were transformed after preparation by CsCl gradient. Cell 
viability was measured by staining of cells with 0.05% Evan’s blue, a total of 200 cells 
were counted in four different experiments. 
 For localization of GFP fusion proteins, protoplasts were prepared and 
transformed in the same manner as in cell viability experiments. Visualization with a 
Zeiss Axioplan 2 fluorescent microscope enabled visualization of GFP fusions while 
nuclear visualization required incubation with 10μM HOECHST 33342 (Sigma) for 30 
minutes. 
2.10 Kinase-Client assay 
 This procedure was carried out as previously described with modifications, the 
synthetic peptide library, PEPscreen peptides (Sigma-Aldrich) contained 2100 peptides 
derived from phosphorylation data of Arabidopsis proteins (Huang and Thelen, 2012). 
For their role as the kinase in the KiC assay, MBP, MBP-AGC1-3, and MBP-AGC1-
3S596D were expressed, purified, and adjusted to a final concentration of 5 μg/μL. Each 
kinase was assayed for auto-catalytic activity, trypsin digested, and subjected to LC-
MS/MS analysis to identify auto-catalytic residues. For the identification of substrate 
peptides, each kinase was incubated with ~100 peptides at a final concentration of 4.5 
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μM. Kinase assays with peptides were incubated at room temperature for 30 minutes and 
quenched by adding an equal volume of 1% formic acid/99% acetonitrile then dried by 
centrifugal-evaporator and frozen at -20°C. Freeze-dried-peptides were suspended in 
40μL of 0.1% formic acid and loaded onto 96-well plates and placed in an autosampler. 
From the autosampler, 10μL of the freeze-dried peptide sample was taken and peptides 
were bound to a C8 Captrap then eluted with a gradient of 1-30% acetonitrile in 0.1% 
formic acid over 15 minutes. Peptides were separated using a “Magic 18” fused silica 
column and analyzed using a stand-alone LTQ-XL with a 1-40% acetonitrile gradient. 
Raw MS files were searched against the sequences of the peptide library, using 
SEQUEST. 
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CHAPTER III 
PDK1 PHOSPHORYLATES AGC1-3 AND ADI3 AT MULTIPLE SITES* 
3.1 Mass spectrometry analysis of SlPdk1 phosphorylated by Adi3 
 From our previous studies we have shown that SlPdk1 phosphorylates Adi3 only 
on Ser residues, phosphorylation of Ser539 accounts for ~ 40–50% of SlPdk1 activity on 
Adi3, and at least one additional Adi3 Ser residue accounts for the remaining 
phosphorylation by SlPdk1 (Devarenne et al., 2006). In an effort to identify the 
additional SlPdk1 phosphorylation site(s) on Adi3 we initially took a mass spectrometry 
(MS) approach. Kinase-inactive Adi3K337Q was phosphorylated by SlPdk1 using non-
radiolabeled ATP, digested with trypsin, and analyzed by tandem MS/MS, which 
identified 20 peptides giving 49% coverage of the Adi3 protein sequence (Figure 8). 
This MS/MS analysis was repeated several times without, an increase in peptide 
coverage of Adi3. Two new phosphorylated Ser residues were found in two separate 
Adi3 peptides; Ser119 and Ser518 (Figure 8, Figure 9, Figure 10). The previously 
identified SlPdk1 phosphorylation activation site in Adi3, Ser539 (Devarenne et al., 
2006), was also identified as a phosphorylated residue (Figure 8 and Figure 11). 
 
 
 
                                                 
* Portions of the following article have been reprinted with permission from: Gray J, 
Nelson Dittrich AC, Chen S, Avila J, Giavalisco P, Devarenne TP (2013) Two Pdk1 
phosphorylation sites on the plant cell death suppressor Adi3 contribute to substrate 
phosphorylation. Biochim Biophys Acta 1834: 1099-1106. Copyright 2013 © by 
Elsevier. 
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Figure 8. Adi3 peptide MS coverage and Pdk1 phosphorylation site identification. 
The Adi3 protein sequence showing peptides identified by MS, alternately highlighted in 
yellow and green, from Pdk1 phosphorylated Adi3 giving 49% coverage of the total 
Adi3 protein. Phosphorylation sites identified by MS or homology to AtAGC1-3 are 
highlighted as indicated. 
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Figure 9. MS/MS spectra of Pdk1 phosphorylated Adi3 peptide with Ser119 
phosphorylation. Trypsin digestion of the kinase inactive, bacterially expressed Adi3 
phosphorylated by bacterially expressed Pdk1 results in a phosphorylated peptide. 
Analysis of this phosphorylated peptide indicates that the 3rd amino acid from the N-
terminus, a serine, is phosphorylated. Analysis of full-length Adi3 protein sequence 
reveals that this site corresponds to Ser119. Although this peptide has another serine at 
position 13, it is not appear to be phosphorylated by Pdk1.
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Figure 10. MS/MS spectra of Pdk1 phosphorylated Adi3 peptide with Ser518 
phosphorylation. Trypsin digestion of the kinase inactive, bacterially expressed Adi3 
phosphorylated by bacterially expressed Pdk1 results in a phosphorylated peptide. 
Analysis of this phosphorylated peptide indicates that the 3rd amino acid from the N-
terminus, a serine, is phosphorylated. Analysis of full-length Adi3 protein sequence 
reveals that this site corresponds to Ser518. This peptide has other residues that could be 
phosphorylated by Pdk1 – Ser9, Thr18, and Ser19 however this spectra indicates that 
those residues are not phosphorylated by Pdk1. 
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Figure 11. MS/MS spectra of Pdk1 phosphorylated Adi3 peptide with Ser539 
phosphorylation. Trypsin digestion of the kinase inactive, bacterially expressed Adi3 
phosphorylated by bacterially expressed Pdk1 results in a phosphorylated peptide. 
Analysis of this phosphorylated peptide indicates that the 3rd amino acid from the N-
terminus, a serine, is phosphorylated. Analysis of full-length Adi3 protein sequence 
reveals that this site corresponds to Ser5139. This residue is the activation-loop residue, 
known to be phosphorylated by Pdk1. This peptide has other residues that could be 
phosphorylated by Pdk1 – Ser1, and Thr7 however this spectra indicates that those 
residues are not phosphorylated by Pdk1. This spectra also indicates that Met2 in the 
peptide is oxidized. 
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3.2 The MS/MS-identified phosphorylation sites do not contribute to SlPdk1 
phosphorylation of Adi3 or Adi3 auto- or trans-phosphorylation 
 In order to confirm or deny that the phosphorylated Adi3 Ser residues identified 
by MS/MS were phosphorylated by SlPdk1, each residue was mutated to Ala in the 
kinase-inactive Adi3K337Q background, the proteins incubated with SlPdk1 in an in vitro 
kinase assay with [γ-32P]ATP, and the level of Adi3 phosphorylation quantified and 
compared to the level of phosphorylation for Adi3K337Q. As we have seen previously 
(Devarenne et al., 2006), the S539A mutation reduces SlPdk1 phosphorylation of Adi3 
by ~ 40% (Figure 12A, lane 4). However, the Ala mutations of the other Ser residues 
identified here by MS/MS did not reduce SlPdk1 phosphorylation of Adi3 and in some 
cases even increased phosphorylation (Figure 12, lanes 2, 3). 
We have previously shown that mutation of Adi3 Ser539 to the phosphomimetic 
Asp greatly increases autophosphorylation and substrate phosphorylation (Devarenne et 
al., 2006; Ek-Ramos et al., 2010; Avila et al., 2012) supporting activation of Adi3 by 
SlPdk1 phosphorylation of this site. Next, we mutated the MS/MS-identified 
phosphorylation sites to Asp and tested autophosphorylation as well as phosphorylation 
of the protein kinase artificial substrate myelin basic protein. As we have seen before, 
the S539D mutation greatly increases Adi3 auto- and trans-phosphorylation (Figure 12B, 
lane 4). The S119D, mutation increased Adi3 autophosphorylation only slightly above 
that of wild-type and not to the extent of S539D (Figure 12B, lane 2), while S518D was 
slightly lower than wild-type (Figure 12B, lane 3). Similar results were seen for  
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Figure 12. Contribution of MS/MS-identified Adi3 phosphorylation sites to 
phosphorylation by SlPdk1 and Adi3 trans-phosphorylation. In (A) and (B), the 
indicated proteins were incubated in an in vitro kinase assay with γ-[32P]ATP. Top panel, 
phosphorimage; bottom panel, coomassie stained gel. Relative values of phosphorylation 
are given below each lane and are representative of two independent experiments. Gray 
diamond, form of MBP-Adi3 used in assay. Gray, open, and black triangles, location of 
MBP-Adi3, MBP-SlPdk1, and myelin basic protein, respectively. The following 
amounts of each protein were used in the assay: MPB-Adi3, 5 μg; MBP-SlPdk1, 1.0 μg; 
myelin basic protein, 5 μg. (A) Ala mutation of the identified phosphorylated Ser 
residues does not reduce Pdk1 phosphorylation of Adi3. (B) Asp mutation of the 
identified phosphorylated Ser residues does not increase Adi3 phosphorylation of myelin 
basic protein. 
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phosphorylation of myelin basic protein by the Asp mutations; only the S539D mutation 
greatly increased the phosphorylation of the substrate (Figure 12B, lane 4). These results 
may suggest that Ser119 and Ser518 are not bona fide SlPdk1 phosphorylation sites and 
may be artifacts of the in vitro kinase assay. These residues are most likely not Adi3 
autophosphorylation sites since the kinase-inactive Adi3K337Q was used for the 
MS/MS analysis. 
3.3 Identification and characterization of AGC1-3, the Arabidopsis thaliana 
sequence homologue of Adi3 
At the same time we were carrying out the MS/MS analysis and characterization 
of the identified Adi3 phosphorylation sites described above, we began to characterize 
the Arabidopsis thaliana sequence homologue of Adi3 to identify Arabidopsis thaliana 
Pdk1 (AtPdk1) phosphorylation sites. A BLAST search of the Arabidopsis genome and 
proteome using the Adi3 cDNA and protein sequences returned gene At2g44830 (a.k.a. 
AGC1-3 (Bogre et al., 2003)) as the closest sequence homologue to Adi3. A comparison 
of AGC1-3 to Adi3 shows that they share 63.8% amino acid identity and have the same 
protein domains that are the hallmarks of the VIIIa group of plant AGC kinases such as a 
PIF, PIF binding pocket, kinase domain, and activation-loop extension (Figure 13A). 
AGC1-3 is 65 amino acids longer than Adi3, which is mainly localized to the region N-
terminal to the kinase domain (Figure 13A). 
There have been minimal studies on AGC1-3. The only experimental  
characterization of AGC1-3 has shown that it is a phosphorylation substrate of AtPdk1 
and that its mRNA is expressed in seedlings, reproductive organs (inflorescences,  
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Figure 13. Auto- and AtPdk1 phosphorylation of AGC1-3. The indicated MBP-
AGC1-3 proteins were incubated in an in vitro kinase assay with γ-[32P]ATP. Top panel, 
phosphorimage; bottom panel, coomassie stained gel; middle panel, quantification of 
AGC1-3 autophosphorylation (A) or phosphorylation by AtPdk1 (B) from at least 3 
independent assays. Error bars indicate standard error. Average value is shown under 
each column. Gray diamond, form of MBP-AGC1-3 used in assay. Gray and open 
triangles, location of MBP-AGC1-3 and GST-AtPdk1, respectively. The following 
amounts of each protein were used in the assay: MPB-AGC1-3, 8 μg, GST-AtPdk1, 
4 μg. (A) AGC1-3 encodes a functional protein kinase. Analysis of wild-type, kinase-
deficient, and constitutively active MBP-AGC1-3 fusion proteins by in vitro 
autophosphorylation assays. (B) Ser596 accounts for 45% of AtPdk1 phosphorylation of 
AGC1-3. Analysis of AtPdk1 phosphorylation of AGC1-3 in in vitro kinase assays. 
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flowers, siliques), and root (Zegzouti et al., 2006). Interestingly, AGC1-3 is not 
expressed in cauline leaves or stems of mature plants (Zegzouti et al., 2006). We have 
shown that AGC1-3 and AtPDK1 interact in a yeast two-hybrid (Y2H) assay in 
reciprocal combinations of the proteins as bait and prey (Figure 14, samples 2, 3) and 
that this interaction was dependent on the presence of the AGC1-3 PIF motif (Figure 14, 
sample 12). 
We next tested the autophosphorylation activity of AGC1-3 using in vitro kinase 
assays. Wild-type AGC1-3 showed a low level of autophosphorylation activity (Figure 
13, lane 1), whereas AGC1-3K392Q, which has a mutation in the Lys residue that 
corresponds to the Lys337 ATP-binding residue in Adi3 (Figure 13A), did not (Figure 
13A, Lane 2). Serine 596 corresponds to the conserved Pdk1 phosphorylation site in the 
activation loop of AGC1-3, and mutation to Ala (S596A) eliminated AGC1-3 
autophosphorylation (Figure 13B, Lane 3), while mutation to Asp (S596D) greatly 
increased this activity (Figure 13B, Lane 4). This would suggest that phosphorylation of 
Ser596 contributes to full activity of AGC1-3. 
Even though AGC1-3 has been shown to be phosphorylated by AtPdk1 (Zegzouti 
et al., 2006), the actual site(s) of phosphorylation was not identified. Thus, we tested the 
contribution of Ser596 to AtPdk1 phosphorylation of AGC1-3. Using the kinase 
deficient AGC1-3K392Q it was seen that AtPdk1 can phosphorylate AGC1-3 (Figure 13C, 
lane 1), and the Ala mutation of Ser596 in the AGC1-3K392Q background resulted  
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Figure 14. AGC1-3 yeast two-hybrid interactions with AtPdk1. The indicated bait 
and prey constructs were tested in the Y2H assay for expression of the lacZ gene on X-
Gal plates (blue = interaction). The Drosophila protein Dorsal was used as a negative 
control and indicate that the AtPdk1/Adi3 interaction is specific. 
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in a loss of ~45% of the AtPdk1 phosphorylation of AGC1-3 (Figure 13C, Lane 2). Both 
of the AGC1-3K392Q and AGC1-3S596A proteins maintain interaction with AtPdk1 (Figure 
13, samples 4, 5). These data would suggest that Ser596 is an AtPdk1 phosphorylation 
site in AGC1-3. 
3.4 N-terminal truncations of AGC1-3 identify Ser269 as a second AtPdk1 
phosphorylation site 
Since MS/MS on SlPdk1 phosphorylated Adi3 was not successful in identifying 
additional phosphorylation sites, we took the alternate approach with AGC1-3 of using 
truncations to identify additional AtPdk1 phosphorylation sites. Successive AGC1-3 100 
amino acid N-terminal deletions up to 400 amino acids, as shown in Figure 13A, were 
constructed in the kinase-inactive AGC1-3K392Q/S596A background and tested for 
phosphorylation by AtPdk1 (Figure 15A). After deletion of the first AGC1-3 100 amino 
acids, phosphorylation by AtPdk1 increased over that of the full length protein (Figure 
15A Lanes 1, 2) suggesting an inhibitory function for these first 100 AGC1-3 amino 
acids for interaction with or phosphorylation by AtPdk1. The AGC1-3Δ200 deletion 
protein did not change the phosphorylation by AtPdk1 compared to AGC1-3Δ100 (Figure 
15A, Lane 3). However, the AGC1-3Δ300 deletion caused a drastic decrease in the 
phosphorylation of AGC1-3 by AtPdk1 (Figure 15A, Lane 4), as did the AGC1-3Δ400 
deletion (Figure 15A, Lane 5), suggesting that an additional AtPdk1 phosphorylation 
site(s) in AGC1-3 exists between amino acids 200 and 300. This was confirmed by 
creating further AGC1-3 N-terminal truncations of 25 amino acids based on the AGC1-
3Δ200/K392Q/S596A protein and testing these proteins for AtPdk1 phosphorylation. The  
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Figure 15. Identification of Ser269 as a second phosphorylation site in AGC1-3. In 
A and C, the indicated proteins were incubated in an in vitro kinase assay with γ-
[32P]ATP. Top panel, phosphorimage; bottom panel, coomassie stained gel; middle 
panel, quantification of AGC1-3 phosphorylation by AtPdk1 from at least 3 independent 
assays. Average value is shown under each column. Error bars indicate standard error. 
Gray diamond, form of MBP-AGC1-3 used in assay. Gray triangles, location of MBP-
AGC1-3K392Q/S595A N-terminal truncation (B) and MBP-AGC1-3 (C) proteins. Open 
triangles, location of MBP-AtPdk1. The following amounts of each protein were used in 
the assay: MBP-AtPdk1, 4 μg; MPB-AGC1-3, 5 μg. (A) Identification of AGC1-3 
Ser269 phosphorylation by AtPdk1 using kinase inactive N-terminally truncated MBP-
AGC1-3K392Q/S596A proteins. (B) Amino acid sequences around the conserved Pdk1 
phosphorylation sites in AGC1-3 (S596) and Adi3 (S539), t he identified second Pdk1 
phosphorylation site in AGC1-3 (S269), the homologous site in Adi3 (S212), and the 
consensus sequence. (C) MBP-AtPdk1 phosphorylation of MBP-AGC1-3 kinase site 
mutants produced in the kinase inactive K392Q background. 
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Figure 15. Continued.   
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AGC1-3Δ275 protein had a large reduction in AtPdk1 phosphorylation indicating a 
second AtPdk1 phosphorylation site in AGC1-3 exists between amino acids 250 and 
275. The reduction in AtPdk1 phosphorylation of the AGC1-3 N-terminal deletions was 
not due to a reduced interaction with AtPdk1 since all the AGC1-3 N-terminal deletions 
were capable of pulling down equal amounts of AtPdk1 (Figure 16). There are eight Ser 
residues within this amino acid 250 to 275 region of AGC1-3. However, only one Ser, 
Ser269, has a similar surrounding sequence as the Ser596 activation loop AtPdk1 site 
(Figure 15B). 
In order to confirm Ser269 as an AtPdk1 phosphorylation site on AGC1-3, this 
amino acid was mutated to Ala in the AGC1-3K392Q and AGC1-3K392Q/S596A backgrounds 
and tested for phosphorylation by AtPdk1. These proteins did not contain 
autophosphorylation activity (Figure 17) indicating that any phosphorylation when 
incubated with AtPdk1 could be attributed to AtPdk1. The AtPdk1 phosphorylation of 
AGC1-3K392Q/S269A was reduced by ~ 40% compared to AGC1-3K392Q (Figure 15C, 
compare Lanes 1, 2) and the double phosphorylation site mutant AGC1-3K392Q/S596A/S269A 
showed a large ~90% decrease in AtPdk1 phosphorylation (Figure 15C, Lane 4). These 
data suggest that both Ser269 and Ser539 are the main AtPdk1 phosphorylation sites in 
AGC1-3, and there may be additional minor phosphorylation sites. 
3.5 Adi3 Ser212 is homologous to AGC1-3 Ser269 and is a second SlPdk1 
phosphorylation site 
We next used the data obtained for the AGC1-3 Ser269 AtPdk1 phosphorylation 
site to identify a potential second SlPdk1 site in Adi3. 
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Figure 16. AGC1-3 N-terminal truncations interact with AtPdk1. The indicated N-
terminal truncated MBP-AGC1-3K337Q/S596A proteins were incubated with GST-AtPdk1 
or MBP for 1 hr at 4°C and the MBP-tagged proteins pulled down with amylose resin. 
Each pull-down was split into two equal fractions and analyzed for the presence of GST-
Pdk1 by α-GST western blot (top panel) and the N-terminal truncated MBP-AGC1-
3K337Q/S596A proteins by α-MBP western blot (bottom panel). Gray diamond, truncated 
form of AGC1-3 in the kinase inactive MBP-AGC1-3K392Q/S595A background used in 
assay. White and gray triangles, location of GST-AtPdk1 and MBP. Small black 
triangles on α-MBP western blot (bottom panel) indicate position of N-terminal 
truncated MBP-AGC1-3K337Q/S596A proteins. 
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Figure 17. Autophosphorylation of the AGC1-3 S269A and S596A mutants in the 
kinase-inactive K392Q background and the Adi3 S212A and S539A mutants in the 
kinase-inactive K337Q background. In A and B, the indicated proteins were incubated 
in an in vitro kinase assay with γ-[32P]ATP. Top panel, phosphorimage; bottom panel, 
Coomassie stained gel. Gray and white diamonds, form of MBP-Adi3 or MPB-AGC1-3 
used in assay, respectively. Gray and white triangles, location of MBP-Adi3 or MPB-
AGC1-3, respectively . 5μg of MPB-Adi3 and 3 μg of MPB-AGC1-3 was used in the 
assay. (A) AGC1-3 autophosphorylation. (B) Adi3 autophosphorylation.  
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An alignment of the Adi3 and AGC1-3 protein sequence shows that Ser212 of Adi3 
aligns with that of AGC1-3 Ser269 (Figure 15B). As with AGC1-3 Ser269, the sequence 
surrounding Adi3 Ser212 is similar to that around the conserved Ser539 activation loop 
SlPdk1 site (Figure 15B) suggesting this may be an SlPdk1 phosphorylation site. The 
contribution of Ser212 toward SlPdk1 phosphorylation of Adi3 was tested using in vitro 
kinase assays. As with AGC1-3 Ser269, Ser212 was mutated to Ala in the kinase-
inactive Adi3K337Q and Adi3K337Q/S539Abackgrounds and tested for phosphorylation by 
SlPdk1. These proteins did not contain autophosphorylation activity (Figure 17B) 
indicating that any phosphorylation when incubated with SlPdk1 could be attributed to 
SlPdk1. The SlPdk1 phosphorylation of Adi3K337Q/S212A was reduced by ~ 40% compared 
to Adi3K337Q (Figure 18A, compare Lanes 1, 2) and the double phosphorylation site 
mutant Adi3K337Q/S212A/S539Ashowed a ~ 74% reduction in SlPdk1 phosphorylation 
(Figure 18A, Lane 4). 
Since we have previously shown that the Adi3S539D phosphomimetic protein has 
increased autophosphorylation (Devarenne et al., 2006), the Adi3S212D phosphomimetic 
protein was analyzed for increased autophosphorylation. The Adi3S212D protein did not 
have increased autophosphorylation over that of wild-type protein (Figure 18B, Lanes 1, 
2) and introducing the S212D mutation into the Adi3S539D background did not increase 
autophosphorylation over that of the Adi3S539D protein alone (Figure 18B, Lanes 3, 4). 
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Figure 18. Evidence for Adi3 Ser212 phosphorylation by SlPdk1. In A and B, the 
indicated proteins were incubated in an in vitro kinase assay with γ-[32P]ATP. Top panel, 
phosphorimage; bottom panel, coomassie stained gel; middle panel, quantification of 
Adi3 autophosphorylation (A) or SlPdk1 phosphorylation of Adi3 (B) from at least 3 
independent assays. Average value is shown under each column. Error bars indicate 
standard error. Gray diamond, form of MBP-Adi3 used in assay. Gray and open 
triangles, location of MBP-Adi3 and SlPdk1-6His (A) or MBP-SlPdk1-6His (C), 
respectively. The following amounts of each protein were used in the assay: MPB-Adi3, 
5 μg; MBP-SlPdk1-6His, 0.5 μg. (A) Adi3 Ser212 is phosphorylated by SlPdk1. (B) 
Ser212 does not contribute to Adi3 autophosphorylation. (C) Separation of SlPdk1-
phosphorylated Adi3. The indicated proteins were incubated in an in vitro kinase assay 
with non-radiolabeled ATP followed by SDS-PAGE using a 1:200 ratio of bis-
acrylamide:acrylamide and stained with coomassie. Different phosphorylated species of 
Adi3 are indicated by black arrowheads next to the band. 2 μg of both MBP-Adi3 and 
MBP-SlPdk1-6His was used in the assay.  
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These data suggest that both Ser212 and Ser539 are SlPdk1 phosphorylation sites 
in Adi3, there is an additional site(s) since there is still 10% of SlPdk1 phosphorylation 
remaining in the Adi3K337Q/S539A/S212A protein, and that phosphorylation of Ser212 does 
not contribute to Adi3 autophosphorylation. 
As additional evidence that Ser212 is an SlPdk1 phosphorylation site on Adi3 we 
analyzed SlPdk1 phosphorylated Adi3 proteins by SDS-PAGE for the identification of 
Adi3 protein band shifts due to phosphorylation. The SDS-PAGE gels used in these 
assays contain a bis-acrylamide:acrylamide ratio of 1:200 rather than the standard 1:37.5 
ratio. Studies from our lab and others have shown that the 1:200 gels are capable of 
efficiently separating phosphoproteins based on single phosphorylation events (Demmel 
et al., 2008; Avila et al., 2012). Adi3 proteins with the non-phosphorylatable S212A and 
S539A mutations in the kinase-inactive Adi3K337Qbackground were phosphorylated by 
SlPdk1 and separated by 1:200 10% SDS-PAGE. The non-SlPdk1 phosphorylated 
proteins appeared as single protein bands (Figure 18C, Lanes 1–4), while the SlPdk1 
phosphorylated proteins were separated into several different protein bands (Figure 18C, 
Lanes 6–9). The Adi3K337Q protein appeared as three distinct protein bands (Figure 18C, 
Lane 6), the Adi3K337Q/S212A and Adi3K337Q/S539A proteins appeared as two distinct protein 
bands (Figure 18C, Lanes 7, 8), and the Adi3K337Q/S2121A/S539A protein appeared as a 
single protein band (Figure 18C, Lane 9). This would suggest that Adi3 exists in three 
different SlPdk1 phosphorylated forms and each Adi3 protein band corresponds to a 
phosphoprotein from SlPdk1 phosphorylation. The protein band seen in 
Adi3K337Q/S212A/S539A presumably contains a minor amount of SlPdk1 phosphorylation 
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since this protein still contains 10% of SlPdk1 phosphorylation (Figure 18A). In order to 
confirm these Adi3 bands as phosphoproteins, we treated SlPdk1 phosphorylated 
Adi3K337Q with λ phosphatase to remove phosphate groups and analyzed by 1:200 10% 
SDS-PAGE. As seen previously, SlPdk1 phosphorylated Adi3K337Q appeared as three 
distinct protein bands (Figure 18C, Lane 10). Treatment with λ phosphatase reduced 
Adi3K337Q to a single protein band (Figure 18A, Lane 11). Taken together, these data 
indicate that the two slower migrating Adi3 bands are due to phosphorylation at Ser212 
and Ser539, while the fastest migrating protein should contain a minimal amount of 
SlPdk1 phosphorylation. λ phosphatase treatment also shifted the migration of SlPdk1 
(Figure 18C, compare Lanes 10, 11) indicating it is also phosphorylated in the assay. 
Interestingly, SlPdk1 did not appear as multiple phosphoprotein bands without λ 
phosphatase (Figure 18C, Lane 10) suggesting a single phosphorylation state for SlPdk1. 
 For a final piece of evidence that Ser212 is phosphorylated in Adi3 by SlPdk1 we 
repeated MS/MS on SlPdk1 phosphorylated Adi3K337Q followed by LC–MS/MS analysis 
on an LTQ-Orbitrap mass spectrometer system as we previously reported (Avila et al., 
2012). This analysis positively identified Ser212 phosphorylation (Figure 19), and 
altogether the data presented indicate that Ser212 is a second SlPdk1 phosphorylation 
site on Adi3. 
3.6 The phosphomimetic mutation of Ser212 and Ser539 contributes to full Adi3 
phosphorylation of Gal83 
Since the phosphomimetic proteins Adi3S212D or Adi3S212D/S539D did not affect 
Adi3 autophosphorylation, we analyzed the contribution of  
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Figure 19. MS/MS spectra of Ser212 of Adi3. Trypsin digestion of the kinase inactive, 
bacterially expressed Adi3 phosphorylated by bacterially expressed Pdk1 results in a 
phosphorylated peptide. Analysis of this phosphorylated peptide indicates that the 3rd 
amino acid from the N-terminus, a serine, is phosphorylated. Analysis of full-length 
Adi3 protein sequence reveals that this site corresponds to Ser212. This peptide has 
other residues that could be phosphorylated by Pdk1 – Ser1, Ser7, Thr9, Ser10, and 
Thr11 however this spectra indicates that those residues are not phosphorylated by Pdk1. 
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Ser212 toward phosphorylation of an Adi3 substrate. We have previously shown that 
Adi3 phosphorylates Gal83, the β-subunit of the tomato SnRK1 protein complex, at 
Ser26 (Avila et al., 2012) and (Dittrich and Devarenne, 2012). The SnRK1 protein 
complex regulates metabolism under numerous situations including resistance to 
pathogens (Halford et al., 2003) and (Halford and Hey, 2009), and the β-subunits of this 
complex control cell localization, substrate specificity, and complex activity (Mitchelhill 
et al., 1997; Vincent and Carlson, 1999; Vincent et al., 2001; Warden et al., 2001). We 
have shown that Adi3 phosphorylation of Gal83 inhibits SnRK1 activity (Avila et al., 
2012). 
 The double Adi3S212D/S539Dphosphomimetic mutant protein has similar activity on 
Gal83 as Adi3 that has been fully phosphorylated by SlPdk1. Phosphorylation of Gal83 
by Adi3S212D showed a twofold increase in Gal83 phosphorylation over wild-type Adi3 
(A, compare Lanes 2 and 3), but did not phosphorylate Gal83 as strongly as 
Adi3S539D (A, compare Lanes 3 and 4). The double phosphomimetic mutant 
Adi3S212D/S539D showed a large fourteen fold increase in Gal83 phosphorylation over 
wild-type Adi3 (A, compare Lanes 2 and 5), and had more Gal83 phosphorylation than 
either single phosphomimetic mutant (A, compare Lanes 3, 4. 5). This would suggest 
that phosphorylation of Ser212 contributes Adi3 substrate phosphorylation. 
Our data indicate that there is an additional SlPdk1 phosphorylation site(s) on 
Adi3 other than Ser212 and Ser539 (Figure 18A), suggesting that this additional 
phosphorylation site(s) may be required for full phosphorylation of substrates by Adi3. 
This was tested by comparing the ability of Adi3S212D/S539D and SlPdk1 phosphorylated 
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wild-type Adi3 to phosphorylate Gal83. For this assay, one sample contained 
Adi3S212D/S539D incubated with Gal83 as in Figure 20A, while in another, wild-type Adi3 
was incubated first with SlPdk1 so that Adi3 would be fully phosphorylated, and then 
Gal83 was added to the assay. The results showed that Adi3S212D/S539D phosphorylated 
Gal83 to a similar level as seen previously (Figure 20B, Lane 5), SlPdk1 could not 
phosphorylate Gal83 (Figure 20B, Lane 6), and the pre-SlPdk1-phosphorylated Adi3 
phosphorylated Gal83 to roughly the same level as Adi3S212D/S539D (Figure 20B, Lane 7). 
The level of SlPdk1 phosphorylation of Adi3K337Q was not affected by the incubation 
with Gal83 (Figure 20B, Lane 8). This would indicate that SlPdk1 phosphorylation of 
both Adi3 Ser212 and Ser539 is sufficient for full Gal83 phosphorylation and that any 
additional SlPdk1 phosphorylation sites on Adi3 do not significantly contribute to Gal83 
phosphorylation. 
3.7 Phosphorylation and nuclear localization of AGC1-3 is correlated to cell 
viability 
As mentioned previously, studies of an Adi3 mutant with the activation loop 
extension deleted led to the identification of a nuclear localization sequence (Ek-Ramos 
et al., 2010). Transient expression of the Adi3 mutant with the activation loop extension 
deleted, as well as the activation loop serine mutated to alanine, reduced cell viability to 
~18%, approximately 30% of the empty vector control (Ek-Ramos et al., 2010). 
Transient expression of Adi3 with point mutations within the activation loop extension 
(K506A/K509A) reduced cell viability to ~30%, which was ~50% of the empty vector 
control (Ek-Ramos et al., 2010). 
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Figure 20. Activation of Adi3 kinase activity toward Gal83 through Ser212 and 
Ser539 phosphorylation. In A and B, the indicated proteins were incubated in an in 
vitro kinase assay with γ-[32P]ATP. Top panel, phosphorimage; bottom panel, coomassie 
stained gel. Middle panel, quantification of Gal83 phosphorylation by Adi3 from at least 
3 independent assays. Average value is shown under each column. Error bars indicate 
standard error. Gray diamond, form of MBP-Adi3 used in assay; open diamond, 
presence or absence of SlPdk1-6His. Gray, black, and open triangles, location of MBP-
Adi3, MBP-Gal83, and SlPdk1-6His, respectively. The following amounts of each 
protein were used in the assay: SlPdk1-6His, 0.2 μg; MPB-Adi3, 0.4 μg; MBP-Gal83, 
2 μg. (A) The Adi3S212D/S539D phosphomimetic mutant has increased kinase activity 
toward Gal83 compared to the single S212D and S539D phosphomimetic mutants. (B) 
Mutating either Ser212 or Ser539 to the phosphomimetic Asp increases Adi3 
phosphorylation of Gal83.
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Cellular fractionation and microscopy studies with a GFP fusion of the non-
phosphorylatable activation loop extension deletion mutant, as well as a GFP fusion of 
the K506A/K509A mutant showed exclusion of the GFP signal from the nucleus and 
localization to many punctate cellular structures that are membranous in nature and 
resemble endosomal vesicles (Ek-Ramos et al., 2010). When the activation loop 
extension deleted mutant was then mutated at the activation loop serine to resemble a 
constitutively active Adi3, cell viability increased to a level slightly higher than the 
empty vector control, and microscopy and fractionation studies indicated that Adi3 
localization was shifted back to the nucleus (Ek-Ramos et al., 2010). From these data, it 
is clear the nuclear localization signal within the activation loop extension and 
phosphorylation of the activation loop serine are both important for subcellular 
localization and cell viability. The NLS within the activation loop extension is conserved 
between Adi3 and AGC1-3 (Figure 21A). Studies were undertaken to determine how 
mutations of the AGC1-3 NLS and activation loop serine impact Arabidopsis protoplast 
cell viability and AGC1-3 localization. As expected, transient expression of the wild 
type AGC1-3 was distributed throughout the cell and did not reduce cell viability 
relative the empty plasmid control (Figure 21B & C). However, cell viability was 
reduced in the NLS, non-phosphorylatable triple mutant – K562A/K565A/S596A to 
~45% or around 70% of the empty plasmid control (Figure 21B). The GFP fusion of the 
K562A/K565A/S596A triple mutant was localized to small punctate cellular structures, 
similar to Adi3 (Figure 21C). When a constitutively active, NLS mutant of AGC1-3 
(K562A/K565A/S596D) was transiently expressed, cell viability was approximately 
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Figure 21. Subcellular localization and cell viability studies of AGC1-3. White arrows are used to indicate the nucleus in 
the field using the nuclear DNA stain Hoechst 3342, the FITC field, as well as the images of the autofluoresence/FITC merge.  
A, The conserved NLS within the activation loop extension of Adi3 and AGC1-3. B, Cell viability of protoplasts, expressing 
GFP-AGC1-3 NLS and activation loop mutants – cells were analyzed by Evan’s blue stain of dead cells, 24hr post-
transfection. C, Protoplasts were analyzed 24hr post-transfection for subcellular localization.  
  70 
65% - essentially a ~5% reduction compared to the empty vector control (Figure 21B). 
GFP analysis of the K562A/K565A/S596D triple mutant indicated that expression of 
AGC1-3 appeared to be found in the nucleus (Figure 21C). 
 These results indicate that the NLS and activation loop serine are involved in 
localization of AGC1-3 to the nucleus. Similarly the NLS and activation loop serine are 
relevant to cell viability in Arabidopsis protoplasts. It appears that cell viability control 
by AGC1-3 is similar to Adi3, as are subcellular localization patterns (Ek-Ramos et al., 
2010). 
3.8 Other AGC VIIIa kinases have multiple Pdk1 phosphorylation sites 
 Considering that AGC1-3 and Adi3 have a phosphorylation site very similar to 
their activation loop motif, we analyzed other members of the AGC VIIIa subfamily to 
determine if they also have a second activation-loop-like Pdk1 phosphorylation site. 
Sequence analysis did not yield any obvious residues to investigate however the second 
AGC1-3/Adi3 site was not identified until mutagenesis studies were conducted. In a 
result similar to Adi3, a previous study with the rice AGC kinase Oxi1, non-activation-
loop Pdk1 phosphorylation was observed but not identified (Matsui et al., 2010). 
Despite the lack of obvious additional Pdk1 phosphorylation sites based on 
sequence analysis and alignment, AGC1-4 and AGC1-7 were selected for further 
analysis (Figure 22). Of the VIIIa subfamily, AGC1-4 at 55% identity is the closest 
relative of AGC1-3. In comparison, AGC1-7 is more distantly related but is 51% 
identical to AGC1-3. To determine if these proteins have additional Pdk1 
phosphorylation sites they were expressed and purified as GST fusion proteins, the  
  71 
AGC1-3   MLEMERVAELKRLPSKGPVSGHLSRRPYLDFETRDAPGMHLESLRERAARYNTGRSVNPT 60 
AGC1-4   -------------------------------MSKQTP--NLESLQDCSSSNYNNANASPV 27 
AGC1-7   ---MLTKPGKKLDSSESTHHTTSSNYPPLDIVHQTPQPRKEMQQKPLFDPKKMDNLIKPE 57 
                                         : .   :  . :        .   .* 
AGC1-3   TTLGRELSQVLNVHREDMMMTQFGGNMNDFQEFEPVVSSVRTMKAKYPLLEIEEIGAADD 120 
AGC1-4   S----------------------------------------------------------- 28 
AGC1-7   P----------------------------------------------------------- 58 
         .                                                              
AGC1-3   DVTCKGSNDMSEEAGSSSFRGVSHPPEPDDMDLITTVYVPISEKNKPDSVCLMKSMSTTK 180 
AGC1-4   --------------GSASFK---------------------TSSNGSEDVRLNNSIS--- 50 
AGC1-7   -------------AGFTNHHRPN----------------PSPKIPSSPGSNMTESQS--- 86 
                       * :..:                     ..   . .  : :* *      
AGC1-3   GPFIEDISLCVPPKKPSPRVLSPAESIVEEPATSLSPFSVARASQNTENSLLPPDSDKEC 240 
AGC1-4   ------LSFCS------------------------------------------------- 55 
AGC1-7   -------NLNTKPNN--------------------------------------------- 94 
                  .:                                                     
AGC1-3   VWDASLPPSTNVSPHSSSVESMNLARAMSIANSSSATSTTQRSDVVLSMDKNYFDRSISM 300 
AGC1-4   ------------------------------SNSVSSEANLEKT----------------- 68 
AGC1-7   ------------------------------NNSNNNSNMSSRS----------------- 107 
                                        ** .     .::  
AGC1-3   VLDSFESTKTSASRASDSSGLSEESSWSNFTGSLNKPHKGNDPWWNAILAIR-TRDGILG 359 
AGC1-4   --QSFDANEANFKRVFAPS----------------KPHKGNDLRWDAIQNVKCSKNEDLG 110 
AGC1-7   --NSIESTSSNPS----------------------KPHTGGDIRWDAVNTLT-SKGVQLG 142 
           :*:::..:. .                      ***.*.*  *:*:  :  ::.  ** 
AGC1-3   MSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMDKASLEDRKKLNRAQTERDILQLLD 419 
AGC1-4   LGHFRLLKKLGCGDIGSVYLAELREMGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLD 170 
AGC1-7   ISDFRLLKRLGYGDIGSVYLVELRGTITYFAMKVMDKASLASRNKLLRAQTEREILSQLD 202 
         :..*:***:** ********.**     .**:*****. * .*:** ******:**  ** 
AGC1-3   HPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYL 479 
AGC1-4   HPFLPTLYSHFETEKFSCLLMEFCSGGDLHILRQKQPGKHFSELAARFYASEVLLALEYL 230 
AGC1-7   HPFLPTLYSHFETDKFYCLVMEFCGGGNLYSLRQKQPNKCFTEDAARFFASEVLLALEYL 262 
         ********:****::* **:**:* **:*: ***:**.* *:* ****:*:********* 
AGC1-3   HMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIKTFDSDPSRRGAFCVQPAC 539 
AGC1-4   HMMGVVYRDLKPENVMVREDGHIMLSDFDLSLQSFVSPTLIQSTSQPSCHIASYCIQPPC 290 
AGC1-7   HMLGIVYRDLKPENVLVRDDGHIMLSDFDLSLRCSVSPTLVKSSSVHAAGGGSGSSRPVG 322 
         **:*:**********:**:*************:. *****::: .  ..  .: . :*  
AGC1-3   MEPTS---ACIIQPSCFLPRSIFPNKNKKNKSRKTQADFFKSHSGSLPELVAEPN-TRSM 595 
AGC1-4   IDPSCKLPVACIQPSCFKPR-FLNNKPRKAKTEKAGSD-------SLPMLIAEPTAARSM 342 
AGC1-7   LIDEDAAVQGCIQPSTFFPRILQSSK----KNRKAKSDFGLFVNGSMPELMAEPTNVKSM 378 
         :          **** * ** :  .*    *..*: :*       *:* *:***. .:** 
AGC1-3   SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFVHELLYGKTPFKGSGNRATLFNVVGEQLK 655 
AGC1-4   SFVGTHEYLAPEIIRGDGHGSSVDWWTFGIFLYELLTGKTPFKGNGNRETLFNVVGQPLK 402 
AGC1-7   SFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFIYELLYGATPFKGQGNRATLHNVIGQALR 438 
         **************:*:****:*********::*** * *****.*** **.**:*: *: 
AGC1-3   FPESPATSYAGRDLIQALLVKDPKNRLGTKRGATEIKQHPFFEGVNWALIRCSTPPEVPR 715 
AGC1-4   FPEG-SISFAAKDLIRGLLTKDPKKRLGFKKGATEIKQHPFFNNVNWALIRSTTPPEIP- 460 
AGC1-7   FPEVPHVSSAARDLIKGLLVKEPQKRIAYKRGATEIKQHPFFEGVNWALIRSATPPHVP- 497 
         ***    * *.:***:.**.*:*::*:. *:***********:.*******.:***.:*    
AGC1-3   QMETEPPPKYGPIDPVGFGSNSKRMMGPPAVSAAAADTKSGG------------------ 757 
AGC1-4   ----------KPIDLSILNETLKSSVQQQGKHSKQSDS-SSG------------------ 491 
AGC1-7   ----------EPVDFSCYASKDKESMAAVDGGGKKNNNGAGGGCSTGGGDNKPNGDCNDP 547 
                    *:*     .. *  :      .   :. :.*                    
AGC1-3   KFLDFEFF 765 
AGC1-4   PYLDFEFF 499 
AGC1-7   DYIDFEYF 555 
          ::***:*  
 
Figure 22. Alignment of AGC1-3, AGC1-4, and AGC1-7. The alignment above shows 
AGC1-3 compared to AGC1-4 and AGC1-7. AGC1-3 and AGC1-4 are 55% identical 
whereas AGC1-7 and AGC1-3 are 51% identical. The activation loop serines are 
underlined and in red, as is the non-activation loop serine identified in AGC1-3 
(Ser269). Additional AGC1-4 and AGC1-7 phosphorylation sites identified by 
NetPhosK are highlighted in yellow. 
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activation-loop serine was mutated to alanine and the ATP-binding site lysine mutated to 
glutamine. Using the phosphorylation site prediction tool NetPhosK 
(www.cbs.dtu.dk/services/NetPhosK/), several prospective phosphorylation sites were 
identified in AGC1-4 and AGC1-7. In the case of AGC1-4, mutation of the activation-
loop residue, Ser343 eliminated virtually all phosphorylation by Pdk1 of the kinase 
inactive AGC1-4 mutant (Figure 23A). On the contrary, mutation of the activation-loop 
residue, Ser379 did not eliminate all phosphorylation of AGC1-7 by Pdk1 (Figure 23B). 
To narrow the scope of the search, only sites with an Arg in the -3 position upstream of 
the phosphorylatable residue were considered based on the Pdk1 phosphorylation motifs. 
Several residues were identified in AGC1-4 & AGC1-7 that had an Arg in the -3 
position relative to a Ser or Thr (Figure 23C & D). The motifs surrounding the two 
residues identified in AGC1-4 are similar to motifs surrounding residues in AGC1-7, 
Thr161 and Thr455 of AGC1-4 are similar to Thr193 and Thr492, respectively, in 
AGC1-7 (Figure 23C & D). Considering that AGC1-4 is not phosphorylated outside of 
the activation loop serine and AGC1-7 is, Thr193 and Thr492 are unlikely to be 
phosphorylated by Pdk1 (Figure 23D). The residues that meet the -3 Arg criteria in 
AGC1-7 are Ser109 and Thr472 and thus are prospective Pdk1 phosphorylation sites. 
Although investigation of non-activation loop Pdk1 phosphorylation sites within other 
AGC VIIIa protein kinases concluded without identifying those residues, Ser109 
phosphorylation was reported in a recent phosphoproteomic analysis of mature 
Arabidopsis pollen (Mayank et al., 2012). In comparison to other AGC VIIIa protein 
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Figure 23. Pdk1 phosphorylation of AGC1-4 and AGC1-7 reveals additional 
phosphorylated residues. In the above figure, kinase inactive mutants of AGC1-4 and 
AGC1-7 are mutated at their activation loop serine by AtPdk1. A, phosphorylation of 
AGC1-4 (gray arrows) by Pdk1 (black arrows) is reduced by ~90% when the activation 
loop serine is mutated to the non-phosphorylatable alanine. The possibility remains that 
AGC1-4 is phosphorylated at other residues by Pdk1 however these residues are 
relatively insignificant to the overall phosphorylation of AGC1-4 by Pdk1. B, 
phosphorylation of AGC1-7 (white arrows) by Pdk1 (black arrows) is reduced by only 
~60% indicating that other residues are phosphorylated by Pdk1. C & D, potential 
residues phosphorylated by Pdk1 in AGC1-4 and AGC1-7 respectively. 
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 kinases, Ser109 of AGC1-7 resembles the activation loop serines of AGC1-8, AGC1-9,  
and KIPK all are preceded by RSN like AGC1-7. Although this non-activation loop 
phosphorylation site is phosphorylated in vivo, whether or not Pdk1 is responsible is 
unknown. 
3.9 Discussion 
The data presented here identify a second SlPdk1 phosphorylation site in Adi3, 
Ser212, that is required for full phosphorylation of the Gal83 substrate. Initially, we 
identified Ser212 by comparison with AGC1-3, the Arabidopsis sequence homologue to 
Adi3, and subsequently phosphorylation of Ser212 was identified by MS/MS. 
Previously, high-throughput studies of Arabidopsis suspension cells treated with the  
flagellin peptide, flg22 implicated Ser137 and/or Ser138 as phosphorylated on AGC1-3 
(Nakagami et al., 2010). Our studies indicate that AtPdk1 does not phosphorylate Ser137 
and/or Ser138, in vitro. Studies regarding AGC1-3’s role in cell death regulation, 
cellular localization, and substrate identification are ongoing. However initial evidence 
supports AGC1-3 as the functional homologue of Adi3. Addition experiments of this 
nature are ongoing, however we have not been successful in obtaining a T-DNA 
knockout line of AGC1-3, suggesting that a homozygous knockout of AGC1-3 may be 
lethal (not shown). This would support, but is not conclusive of a function for AGC1-3 
similar to Adi3 in cell death suppression. Identification of AGC1-3 substrates would also 
help to gauge the function of this kinase. Experiments are currently ongoing toward this 
end. Once AGC1-3 substrates are identified, it will be of importance to test the 
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contribution of Ser269 phosphorylation toward substrate phosphorylation for 
comparison with Adi3. 
 Similar to Adi3, there appears to be a correlation between cell-death suppression, 
subcellular localization of AGC1-3, activation-loop phosphorylation, and the NLS of 
AGC1-3 (Figure 21). Previous work has supported AGC1-3 as a dynamic protein, a 
phosphoproteomic analysis of cultured Arabidopsis cells treated with flg22, AGC1-3 
was located at the PM and phosphorylated at the activation loop serine (Nuhse et al., 
2007). Meanwhile, in a study of protein movement in response to cold treatment, a 
fragment of AGC1-3 was identified in isolated nuclei in a 2-D gel (Bae et al., 2003). 
With the small amount of AGC1-3 publicly available data and localization data these 
from these GFP-AGC1-3 studies, AGC1-3 appears to be a dynamic protein with 
differential localization and phosphorylation states.  
 We also observed that the Ala mutation of AGC1-3 activation site (S596) 
eliminated autophosphorylation activity (Figure 13B), while we have previously seen 
that the Adi3 activation site Ala mutation (S539A) does not eliminate 
autophosphorylation (Devarenne et al., 2006) and (Ek-Ramos et al., 2010). Differences 
in the effects of activation site Ala mutation in mammalian AGC kinases also range from 
inactivation to no effect on catalytic activity. For example, the activation site Ala 
mutations in PKCα and β isotypes produce an inactive protein, while in the PKCδ 
isotype the activation site Ala mutation maintains activity (Parekh et al., 2000) and 
(Stempka et al., 1997). Thus, it appears that the plant AGC kinases contain many of the 
properties that have been seen in mammalian AGC kinases. 
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 Our data also indicate that there is an additional Pdk1 phosphorylation site(s) on 
Adi3 that accounts for approximately 10% of the total Pdk1 phosphorylation. Given the 
difficulty we have experienced in identifying Adi3 peptides by MS/MS, it seems that 
other conventional methods such as Ala scanning mutagenesis and/or phosphopeptide 
mapping may be useful in this effort. Since our studies have shown that Ser539 and 
Ser212 are required for full substrate phosphorylation by Adi3, any additional Pdk1 
phosphorylation sites on Adi3 may be involved in stabilizing the Adi3 protein, 
controlling Adi3 autophosphorylation, or regulating phosphorylation of substrates other 
than Gal83. It should also be noted that it still needs to be determined if these Adi3 
residues are phosphorylated by Pdk1 in plant and if they have the same function in vivo 
as we have shown here by in vitro assays. 
 It is interesting to note the differences seen here for a plant AGC kinase 
compared to mammalian AGC kinases. The three main phosphorylation sites found on 
mammalian AGC kinases (activation site, PIF site, turn motif site) are all phosphorylated 
by different kinases and each has a different role in AGC kinase regulation (Pearce et al., 
2010) and (Hauge et al., 2007). In the case of plants, or at least for Adi3, AGC1-3, and 
AGC1-7, it appears that Pdk1 is responsible for the multiple phosphorylation events on 
AGC kinases and at least two of these are required for full kinase activity on substrates. 
It will be of importance to determine all Pdk1 phosphorylation sites on Adi3 and 
determine their roles in activity or conformation stabilization. 
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CHAPTER IV 
IDENTIFICATION OF AGC1-3 SUBSTRATES 
4.1 Identification of AGC1-3 and AGC1-3S596D substrates with the KiC assay 
In order to define other components involved in the signaling regulated by 
AGC1-3, a collaboration with Nagib Ahsan, a post-doctoral researcher in Dr. Jay 
Thelen’s lab at the University of Missouri, was established. Using both the wild type 
AGC1-3 and the constitutively active mutant AGC1-3S596D in the KiC assay, substrate 
peptides were identified along with their corresponding full-length proteins. Any 
substrates of AGC1-3 are also potential substrates of Adi3, thus data derived from 
studies with AGC1-3 will also potentially benefit Adi3 signaling. 
4.2 Autophosphorylation of AGC1-3 
 Prior to peptide library screening with the KiC assay, AGC1-3 and AGC1-3S596D 
were assayed to identify auto-phosphorylation sites of each respective protein. After 
incubation with ATP, each protein was trypsin digested and analyzed by MS/MS. When 
incubated with ATP, AGC1-3 auto-phosphorylates at two residues, Ser516 and Thr518 
(Figure 24). On the contrary, MS/MS analysis did not support AGC1-3S596D auto-
phosphorylation of Ser516 and Thr518; however it did support phosphorylation of Ser81 
and Ser131 (Figure 25). All four of these phosphorylation sites are unique and are not 
present in the PhosPhAt database.   
4.2 Peptides phosphorylated by AGC1-3  
 Using the KiC assay, a total of 26 peptides were identified as potential substrates 
of wild type AGC1-3   
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Figure 24. MS/MS spectra of auto-phosphorylation of AGC1-3. Trypsin digestion of 
the wild-type, bacterially expressed AGC1-3 phosphorylates itself at several residues. 
Analysis of this phosphorylated peptide indicates that the 4th amino acid from the N-
terminus, a serine, is phosphorylated. Likewise, the 5th amino acid from the N-terminus, 
a threonine, is phosphorylated. These two phosphorylated residues correspond to Ser516 
and Ser518. 
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Figure 25. MS/MS spectra of auto-phosphorylation of AGC1-3S596D. Trypsin 
digestion of the constitutively active, bacterially expressed AGC1-3 phosphorylates 
itself at one residue. Analysis of this phosphorylated peptide indicates that the 7th amino 
acid from the N-terminus, a threonine, is phosphorylated. Thr7 in this peptide 
corresponds to Thr81 in the full-length AGC1-3 protein. 
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(Table 2). All peptide sequences were subjected to BLASTp searches of the Arabidopsis 
genome. From the BLASTp searches, AGIs (Arabidopsis Genome Identification) were 
identified, with their annotated genes. The PhosPhAt database was searched to determine 
if in vivo MS data was available for any of the candidate proteins 
(http://phosphat.mpimp-golm.mpg.de). The PhosPhAt database is a collection of 
Arabidopsis MS data collected from publications as well as unpublished data. Of the 26 
AGC1-3 phosphorylated peptides in the KiC dataset, all but 2 of the proteins have 
supporting data from PhosPhAt. Of the 24 remaining peptides, 19 have at least one 
phosphorylated residue identified in the KiC assay that is also found in the PhosPhAt 
database (Table 2). Although AGC1-3 is a Ser/Thr kinase, 5 KiC peptides have 
phosphorylated tyrosines and one of those 5 is present in the PhosPhAt database (Table 
2). The protein in question is a GDSL-like lipase/acylhydrolase with a Thr 
phosphorylated immediately before the phosphorylated Tyr (At3g62280). Thus although 
unexpected, AGC1-3 could possibly phosphorylate tyrosines on certain substrates. 
4.3 19 peptides are phosphorylated by AGC1-3S596D 
 The same protocol was used for peptides phosphorylated by AGC1-3S596D – first 
a BLASTp search, then followed by PhosPhAt searches. All of the 19 peptides 
phosphorylated by AGC1-3S596D, 11 had PhosPhAt results indicating the phosphorylated 
residue from the KiC assay is also phosphorylated within the PhosPhAt database (Table 
3). In a result similar to the wild type protein, several of the phosphorylated peptides 
have phosphorylated tyrosines. Of the five that have phosphorylated tyrosines, the 
peptide that appears to be phosphorylated by 
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Table 2. AGC1-3 phosphorylated peptides. The peptides identified as being phosphorylated by AGC1-3 as well as their 
Arabidopsis genome identifiers, if the protein is phosphorylated according to data in the PhosPhAt database, as well as the 
peptide in the PhosPhAt database. Phosphorylated residues are identified in bold red font. 
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Table 3. Peptides phosphorylated by AGC1-3S596D. Peptides phosphorylated by the constitutively active mutant of AGC1-3. 
19 peptides are phosphorylated by AGC1-3S596D and 11 of the peptides have supporting data available in the PhosPhAt 
database. 
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AGC1-3S596D happens to be the same peptide phosphorylated by AGC1-3 - a GDSL-like 
lipase/acylhydrolase (At3g62280). 
4.4 AGC1-3S596D phosphorylates pyrophosphate-dependent phosphofructokinase 
 One peptide identified in the KiC screen for peptides phosphorylated by AGC1-
3S596D was a 17 amino acid peptide, phosphorylated at two residues, Thr2 and Thr6 
(Figure 26). A BLASTp search of the Arabidopsis genome presents a 100% hit for 
pyrophosphate dependent phosphofructokinase (PFP) (At1g12000) (Table 3). The two 
residues implicated, Thr2 and Thr6 of the peptide, correspond to Thr8 and Thr12 of the 
full-length protein. A search for this protein in the PhosPhAt database reveals 
phosphorylated peptides. Two different phosphoproteomic analyses identified Thr12 and 
Ser16 phosphorylation, but none of the reported peptides covered Thr8 (Reiland et al., 
2009; Reiland et al., 2011). 
 Although the peptide data from the KiC assay implicates PFP as an AGC1-3 
substrate, the full-length protein must be assayed to confirm phosphorylation by AGC1-
3. For these studies, AGC1-3 was incubated with a GST-PFP fusion protein for 60 
minutes. In a parallel reaction, AGC1-3 was activated by pre-incubation with AtPdk1 for 
30 minutes followed by the addition of GST-PFP and subsequent incubation for 30 
minutes. Incubation of PFP with radiolabeled ATP produced no visible radiolabeled 
protein – identical to PFP with AtPdk1 and ATP (Figure 27, lane 1 & 4). Meanwhile, 
incubation of PFP with AGC1-3 and ATP produced 2-fold increase compared to the 
negative control (Figure 27, lane 2). The most profound difference resulted from pre-
incubation of AGC1-3 with AtPdk1 and ATP followed by the addition of PFP  
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Figure 26. Mass spectra of At1g12000 peptide. The above spectra comes from the KiC 
assay with the constitutively active AGC1-3 and the peptide library. This peptide in 
particular corresponds to At1g12000 – pyrophosphate dependent phosphofructokinase 
(PFP). This peptide is phosphorylated at Thr2 and Thr5, which correspond to Thr8 and 
Thr12 in the full-length protein. 
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Figure 27. AGC1-3 and AtPdk1 activated AGC1-3 phosphorylation of PFP. The 
indicated proteins were incubated in an in vitro kinase assay with γ-[32P]ATP. Top panel, 
phosphorimage; bottom panel, coomassie stained gel. Middle panel, quantification of 
PFP phosphorylation by AGC1-3 from at least 3 independent assays. Average value is 
shown under each column. Error bars indicate standard error. Open triangle, form of 
MBP-AGC1-3 used in assay; black triangle, presence or absence of MBP-AtPdk1; Gray 
triangle, form of GST-PFP used in assay. The AGC1-3 pre-incubated with AtPdk1 has 
increased phosphorylation of PFP, compared to PFP incubated with AGC1-3 (lane 2), 
PFP alone (lane 1), and PFP incubated with AtPdk1 (lane 4). 
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(Figure 27, lane 3). The peptide for PFP was found in the KiC assay with AGC1-3S596D 
but not AGC1-3, therefore it is not particularly surprising that AGC1-3 pre-incubated 
with AtPdk1 phosphorylates PFP to a greater degree than AGC1-3 without AtPdk1 pre-
incubation. 
Based on the KiC assay, AGC1-3S596D phosphorylates PFP at Thr8 and Thr12, a 
double mutant of PFPT8A/T12A was expressed and assayed with AGC1-3, pre-incubated 
with AtPdk1. The anticipated result was a total loss of phosphorylation. However, both 
the double mutant and wild type protein were phosphorylated at approximately the same 
level by AGC1-3. This result indicates that AGC1-3 phosphorylates PFP at another 
residue(s), though whether or not AGC1-3 phosphorylates at Thr8 and Thr12 in the full-
length protein remains to be discovered; the nature of the GST-fusion conceivably 
precludes Thr8 and Thr12 phosphorylation. 
4.5 Impact of phosphorylation on PFP activity 
In order to analyze the impact of phosphorylation of Thr8 and Thr12 on PFP 
activity, wild type PFP and PFPT8D/T12D were purified as GST-fusions. PFP activity was 
evaluated in the same way that PFK1 activity is monitored, with slight modifications. 
Activity of PFP can be measured by coupling its activity to the oxidation of NADH as 
previously described (Kimmel and Reinhart, 2000). The only difference between the 
assay for PFK1 activity and PFP activity is PPi is used in place of ATP as the substrate. 
All of the components of the reaction were confirmed to be functional, however neither 
PFP nor PFPT8D/T12D were catalytically active (data not shown). This lack of activity is 
potentially attributable to the absence of a regulatory α-subunit. 
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4.6 Discussion 
The data presented here identify a total of 26 and 19 peptides as substrates of 
AGC1-3 and AGC1-3S596D, respectively. Annotated as a Ser/Thr protein kinase, AGC1-3 
phosphorylates peptides at serines, threonines, and somewhat surprisingly, tyrosines. Of 
the 26 peptides phosphorylated by AGC1-3, 8 peptides are also phosphorylated by 
AGC1-3S596D, the constitutively active mutant. While 8 peptides are substrates to both 
AGC1-3 and AGC1-3S596D, it is somewhat surprising that there are peptides that are 
substrates of AGC1-3 but not AGC1-3S596D. The difference in substrate peptides is 
surprising based on the phosphorylation of GAL83 by Adi3 and Adi3S539D. It is entirely 
possible that some of these full-length proteins are substrates of both AGC1-3 and 
AGC1-3S596D however the peptide was not identified in the MS/MS analysis. Ultimately 
if the interaction between AGC1-3 and its substrates is comparable to Adi3 and GAL83, 
the substrates will undergo modest phosphorylation by AGC1-3 and significantly higher 
phosphorylation by AGC1-3S596D and AGC1-3S269D/S596D. However the possibility does 
exist that AGC1-3 and AGC1-3S596D are structurally different enough from one another 
that their substrates are unique. This, however, is worth pursuing through in vitro kinase 
assays with full-length proteins, rather than further work with peptides.  
 After conducting BLASTp searches of the Arabidopsis genome with the 
substrate peptide sequences, all peptides were matched to genes in the Arabidopsis 
genome. Additional analysis of the peptide sequences and full-length protein sequences 
in the PhosPhAt database revealed phosphopeptides for many of the substrates (Table 2 
& Table 3). In many cases, the phosphopeptides identified in the KiC assay are identical 
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to phosphopeptides identified in previous in vivo phosphoproteomic studies reported in 
the PhosPhAt database (Nuhse et al., 2007; Nakagami et al., 2010). The presence of a 
phosphopeptide in both the KiC dataset and the PhosPhAt database suggests that the 
KiC-identified substrates could be in vivo substrates of AGC1-3 or AGC1-3S596D. 
After analyzing the substrate peptide sequences and the proteins that have those 
peptide sequences, AGC1-3 may have substrates involved in many different fundamental 
processes, like metabolism and transcription. In the KiC assay with AGC1-3S596D, 
several particularly interesting proteins were identified. A 17 AA peptide, 
phosphorylated at Thr2 and Thr6, corresponds to the N-terminus of a 566 AA protein, 
pyrophosphate-dependent phosphofructokinase (PFP) (At1g12000) (detailed below in 
“Literature review of PFP”). The two residues implicated in the KiC assay correspond to 
Thr8 and Thr12 of PFP. In an in vitro kinase assay with AGC1-3 and AGC1-3 + AtPdk1, 
it is apparent that when activated by AtPdk1, AGC1-3 does phosphorylate PFP (Figure 
27). In reference to the PhosPhAt database, Thr12 is phosphorylated in a peptide within 
the PhosPhAt database. On the contrary, no peptides in the PhosPhAt database cover 
Thr8. After mutagenesis of PFP to create PFPT8A/T12A and subsequent in vitro kinase 
assays, it is apparent that AGC1-3 activated by AtPdk1 does not phosphorylate those two 
residues (Figure 28). Although experiments have not been conducted to analyze this 
residue, the PhosPhAt database indicates that Ser16 is phosphorylated – whether or not 
AGC1-3 phosphorylates that residue remains to be seen. Currently wild-type PFP 
phosphorylated by AtPdk1 activated AGC1-3 is being analyzed by MS/MS. One 
possible explanation for why the PFPT8A/T12A protein is phosphorylated at the same level  
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Figure 28. AGC1-3 phosphorylation of PFP and PFPT8A/T12A. The indicated proteins 
were incubated in an in vitro kinase assay with γ-[32P]ATP. Top panel, phosphorimage; 
bottom panel, coomassie stained gel. Middle panel, quantification of PFP 
phosphorylation by AGC1-3 from at least 3 independent assays. Average value is shown 
under each column. Error bars indicate standard error. Open triangle, form of MBP-
AGC1-3 used in assay; black triangle, presence or absence of MBP-AtPdk1; Gray 
triangle, form of GST-PFP used in assay. AGC1-3 phosphorylation of PFP (lane 1) is 
comparable to phosphorylation of PFPT8A/T12A (lane 2). 
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as PFP is that PFP is expressed as a N-terminal GST-fusion protein, and since the 
phosphorylation sites are on the N-terminus, access to them may be impeded. Expressing 
PFP with an affinity-tag on its C-terminus will eliminate the possibility of N-terminal 
fusion protein interference. However, it is clear that since AtPdk1-activated AGC1-3 
phosphorylates PFP and PFPT8A/T12A at the same level, there are other 
phosphorylation sites – possibly Ser16 but possibly elsewhere in the protein. Initial work 
into catalytic activity of PFP and PFPT8A/T12A was unsuccessful as no activity was 
observed. Once the AGC1-3 phosphorylation of PFP is resolved, experiments with PFP 
and the impact of phosphorylation of PFP should be resumed. 
 In this chapter, I have described the results of the KiC assay used to identify 
substrates of AGC1-3 and its constitutively active mutant AGC1-3S596D. Substrates 
ranging from involvement in central metabolism to cell cycle control were identified in 
this screen. Many of the substrate phosphopeptides have supporting phosphopeptide data 
from in vivo phosphoproteomic analyses – whether or not the in vivo phosphorylation is 
done by AGC1-3 is unknown. 
With AGC1-3’s connection to cell-death regulation, the substrates present 
interesting possible narratives. For instance does, AGC1-3 phosphorylation of the gene 
product of At1g75990, 26S proteasome regulatory subunit S3, change proteasome 
activity? Likewise, does phosphorylation of PFP increase enzyme activity in an effort to 
deplete the cell of resources – could PFP activation be a link to the HR? Ultimately there 
are several additional levels to this project and successful utilization of the data 
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generated from the KiC assay. First and foremost, phosphorylation of these substrates 
must be confirmed in vitro and then, in vivo. 
4.7 Supplemental literature review of PFP 
4.7a Phosphofructokinase 
Phosphofructokinase 1 (PFK1) is an enzyme often investigated for an insight into 
allostery as well as its role in glucose metabolism (Mosser et al., 2012). PFK1 produces 
fructose 1,6-bisphosphate (F1,6BP) by transferring the ϒ-phosphate from ATP to 
fructose 6-phosphate (F6P) (Mosser et al., 2012). PFK1 is a key regulatory step in 
glycolysis and requires ATP, F6P, and Mg2+ for catalysis (Mosser et al., 2012). As a 
regulatory step in glycolysis it is highly regulated, by a multitude of effectors. For 
example, it is activated by AMP and ADP, while it is inhibited by phosphoenolpyruvate 
(Mosser et al., 2012) (Figure 29A). F6P is also phosphorylated by the enzyme 
phosphofructokinase 2 (PFK2), to produce fructose 2,6-bisphosphate (F26BP) (Kotlarz 
and Buc, 1981) (Figure 29B). F26BP is an activator of PFK1 and is dephosphorylated by 
F26BPase to produce F6P, which PFK1 can once again use in glycolysis (El-Maghrabi 
et al., 1982). Both PFK1 and PFK2 are ATP dependent phosphofructokinases and are 
highly conserved in all organisms able to utilize glucose as a fuel source. 
4.7b Pyrophosphate dependent phosphofructokinase (PFP) 
 An enzyme that is similar to PFK1 and PFK2 but not nearly as ubiquitous is 
pyrophosphate dependent phosphofructokinase (PFP) (Bruchhaus et al., 1996). PFP 
activity has been reported in a number of plants, bacteria, and algae 
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Figure 29. Catalytic activities of PFK1, PFK2, and PFP. All three of these enzymes utilize fructose 6-phosphate A, PFK1 
and C, PFP both make fructose 1,6-bisphosphate, meanwhile B, PFK2 produces fructose 2,6-bisphosphate. The significant 
difference is the dephosphorylation of F16BP and F26BP rather than requiring a specific phosphatase, PFP can catalyze this 
reaction itself.
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(Carnal and Black, 1983; Nielsen et al., 2004). One of the most profound differences 
between PFP and PFK1 is substrate preference. Unlike PFK1, PFP uses inorganic 
pyrophosphate as a substrate to phosphorylate F6P and yield F16BP (Wong et al., 1990) 
(Figure 29C). However that is only half of the capacity of PFP because of its ability to 
also utilize inorganic phosphate as a substrate in the reciprocal reaction, 
dephosphorylation of F16BP to produce PPi (Vincent et al., 2001) (Figure 29). Since 
PFP can catalyze reciprocal reactions, it is likely under strict regulation – possibly in 
multiple ways like PFK1 (Mosser et al., 2012). 
PFP and PFK1 are quite dissimilar in primary and higher order structure, 
comparison of PFP (At1g12000; accession # NM_101072) and PFK1 (At4g29220; 
accession # NM_119066) from Arabidopsis thaliana reveals only 15% identity (Figure 
30). The active sites of PFP and PFK1 have similarities, each is made up of 17 invariant 
residues (Shirakihara and Evans, 1988; Moore et al., 2002) (Figure 30). Of the 17 
invariant residues, 12 of them are conserved between PFP and PFK1 (Shirakihara and 
Evans, 1988; Moore et al., 2002) (Figure 30). Study of PFP from the protist Entamoeba 
histolytica revealed a single active site residue was responsible for substrate specificity 
(Chi and Kemp, 2000). Three active site residues of PFK1 make up a DGS triplet and in 
PFP, that triplet is DDS (Figure 30). Mutation of E histolytica PFP DDS to DGS enables 
utilization of ATP approximately 4,000x more efficiently and essentially eliminates PPi 
as a substrate (Chi and Kemp, 2000). A Gly-Asp mutation is a significant mutation and 
produces a significant change in enzyme activity. 
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PFK1   MSSSVPNS-DRKIVTGPAGYILEDVPHFSDDFPD---HPTYPNPLQDNAAYSVVKQYFVD 56 
PFP    MAPALAVTRDLTAVGSPENAPAKGRASVYSEVQSSRINNTLPLPSVLKGAFKIVEGPASS 60 
       *:.::. : * . * .* .   :. . . .:. .   : * * *   :.*:.:*:    .   
 
PFK1   EDDTVPQKIVVHPDSPRGTHFRRAGPRQRVYFESDDVLACIVTCGGLCPGLNTVIREIVC 116 
PFP    AAGNPDEIAKLFPG-LYGQPSVAVVPDQDAPSSAPKLKIGVVLSGGQAPGGHNVISGLFD 119 
         ..  :   :.*.   *     . * * .  .: .:   :* .** .** :.**  :.    
 
PFK1   GLSYMYGVKRILGIDGGYRGFYARNTIHLDLKTVNDIHRSGGTILGTSRGG-----HNTT 171 
PFP    YLQERAKGSTFYGFKGGPAGIMKCKYVELNAEYIQPYRNQGGFDMICSGRDKIETPDQFK 179 
        *.     . : *:.**  *:   : :.*: : ::  :..**  :  *  .     .: . 
 
PFK1   KIVDSIQDRGINQVYIIGGDGSQKGAAAIFEEIRKRKLKVAVAGIPKTIDNDIPIIDR-- 229 
PFP    QAEETAKKLDLDGLVVIGGDDSNTNACLLAENFRSKNLKTRVIGCPKTIDGDLKCKEVPT 239 
       :  :: :. .:: : :****.*:..*. : *::*.::**. * * *****.*:   :      
 
PFK1   SFGFDTAVEEAQRAINAAHVEATSFENGIGLVKLMGRYSGFIAMHATLASRD----VDCC 285 
PFP    SFGFDTACKIYSEMIGNVMIDARSTGKYYHFVRLMGRAASHITLECALQTHPNITIIGEE 299 
       ******* :  .. *. . ::* *  :   :*:**** :..*::..:* ::     :.     
 
PFK1   LIPESPFFLEGSGGLFEFIDKRLKESGHMVIVIAEGAGQDLLSESMKESTTLKDASGNKL 345 
PFP    VSAQKQTLKNVTDYMVDVICKRAELGYNYGVILIPEGLIDFIPEVQELIAELNEILANEV 359 
       : .:.  : : :. :.:.* ** : . :  :::   .  *::.*  :  : *::  .*::   
 
PFK1   LQDIGLWISQRIKDHFAKKMTLTLKYIDPTYMIR-------------------------- 379 
PFP    VDENGLWK-KKLTEQSLKLFDLLPEAIQEQLMLERDPHGNVQVAKIETEKMLIQMVETEL 418 
       ::: ***  :::.::  * : *  : *:   *:. 
 
PFK1   --------------------------AVPSNASDNVCCTL------LAQSAVHGVMAGYN 407 
PFP    EKRKQAGAYKGQFMGQSHFFGYEGRCGLPTNFDATYCYALGYGAGVLLNSGKTGLISSVG 478 
                                 .:*:* . . * :*      * :*.  *:::. . 
 
PFK1   GFTVGLVNGRHTYIPFNRITEKQNKVVITDRMWARLLSSTNQPSFMKQADKIHSNQLVG- 466 
PFP    NLAAPVEEWTVGGTALTALMDVERRHGKFKPVIKKAMVELEGAPFKKFASLREEWALKNR 538 
       .::. : :      .:. : : :.:    . :  : : . : ..* * *.  ..  * .    
 
PFK1   --EPGTMKW------------------- 473 
PFP    YISPGPIQFTGPGSDSLSHTLLLELGAQ 566 
         .**.:::  
 
Figure 30. Sequence alignment of Arabidopsis PFP and PFK1. Alignment of PFK1 
and PFP from Arabidopsis thaliana. 17 invariant residues of PFK1 are highlighted in 
green, 17 invariant residues of PFP are highlighted in red. 
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A structural comparison of PFK1 and PFP reveals that PFP is typically an (αβ)2 
heterotetramer or a heterodimer (αβ) made up of a regulatory α-subunit and a catalytic β-
subunit, whereas PFK1 is more commonly a homotetramer (Carlisle et al., 1990; Moore 
et al., 2002). The organization of subunits is significant because bacterial PFK1 subunits 
make contacts that compose the active site of the enzyme (Ladror et al., 1991). Whether 
or not the α- and β-subunits of PFP make contacts that compose the active site is 
unknown. 
Regarding the role(s) PFP plays in central metabolism, a consensus has yet to 
emerge. In the actinomycete, Amycolatopsis methanolica, PFP and PFK1 are both 
present, however their activity varies based on carbon source (Alves et al., 2001). When 
grown on glucose, PFP specific activity is 180mU/mg whereas PFK1 is 0mU/mg (Alves 
et al., 2001). Analysis of roots from plants unable to form symbiotic relationships with 
mycorrhizal fungi, PFP activity is significantly increased in response to phosphate 
starvation (Murley et al., 1998). In both of these circumstances, PFP responds to nutrient 
availability – altering activity based on carbon source and phosphate availability, 
however if these sorts of responses are universal remains to be seen. 
4.7c Regulation of PFP and enzymes of central metabolism by phosphorylation 
PFPs are divided into two categories, those whose activity is independent of 
F26BP (termed type I PFPs) and those that are activated by F26BP (termed type II PFPs) 
(Bruchhaus et al., 1996). In contrast, there is no subclassification of PFK1 as they are all 
allosterically activated by F26BP to increase flow of metabolites through glycolysis 
(Bruchhaus et al., 1996; Dang, 2013). 
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Currently there is no data regarding the impact phosphorylation has on PFP 
activity; protein phosphorylation, however, does have physiological relevance to PFK1 
and other enzymes of central metabolism. In the mollusk Mytilus galloprovincialis, 
phosphorylation of PFK1 has been reported to increase enzyme activity three- to four-
fold (Fernandez et al., 1998). On the contrary, phosphorylation of rabbit PFK1 does not 
appear to have any affect on enzyme activity (Foe and Kemp, 1984). It has been shown 
that 85kDa PFK1 from Aspergillus niger is proteolytically cleaved, eliminating PFK1 
activity (Mesojednik and Legisa, 2005). However, PFK1 activity is recovered in vitro 
when the resulting 49kDa product is phosphorylated by protein kinase A (Mesojednik 
and Legisa, 2005). How often PFK1 undergoes proteolytic cleavage and subsequent 
phosphorylation in vivo is not clear, nor what conditions could produce this degradation 
(Mesojednik and Legisa, 2005). However, this is an additional example of 
phosphorylation of PFK1 activating enzyme activity. Much of the research pertaining to 
regulation of PFK1 is centered on inhibition/activation by metabolites like citrate and 
F26BP. 
4.7d PFP in plants 
PFP has been identified in a number of different plants including Solanum 
lycopersicum, Zea mays, and Arabidopsis thaliana (Nielsen et al., 2004; Obiadalla-Ali et 
al., 2004; Guo et al., 2012). Plant PFPs are class II enzymes because they are 
allosterically activated by F26BP (Bruchhaus et al., 1996; Nielsen et al., 2004). F26BP 
levels seem to introduce a highly complex control of PFP. In rice seedlings and in 
carrots, reduced oxygen levels lead to an increase of F26BP levels which are speculated 
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to activate PFP to facilitate adaptation of glycolysis to lower oxygen concentrations 
(Nielsen et al., 2004). In contrast, increased oxygen levels in potato tubers also result in 
increased F26BP levels, possibly to activate PFP (Nielsen et al., 2004). F26BP activation 
of PFP is not specifically directed in the gluconeogenic or glycolytic direction, in fact 
F26BP has been shown to activate in both directions (Nielsen et al., 2004). Ultimately 
the physiological role and importance of PFP remains to be clearly elucidated – however 
it does provide a unique metabolic alternative to ATP-driven glycolysis and 
gluconeogenesis. 
Unlike its prokaryotic counterparts, PFP in plants exists as an (αβ)2 
heterotetramer consisting of regulatory (α) and catalytic (β) subunits (Moore et al., 
2002). How each subunit contributes to complex activity has not been explicitly defined 
through in vitro studies, however studies of the hard-endosperm maize mutant, QPM 
(quality protein maize) and tomato suggest both subunits are required for enzyme 
activity (Wong et al., 1990; Guo et al., 2012). In warm climates, QPM is more successful 
than the soft-endosperm maize mutant, opaque2; a significant difference between QPM 
and opaque2 lines is the expression level of the α-subunit of PFP (Guo et al., 2012). The 
significance of higher levels of the α-subunit is that in a heat stressed environment, ATP-
dependent HSPs burden the cell by utilizing ATP that would otherwise be used for other 
cellular processes (Guo et al., 2012). While HSP levels are lower in QPM, PFP levels are 
elevated and induced in response to heat stress. Therefore PFP activity could reduce the 
ATP-requirement of glycolysis, thus enabling HSP activity without impeding central 
metabolism (Guo et al., 2012). Additionally, glycolytic PFP activity is increased in the 
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QPM endosperm while the reverse activity, dephosphorylation of F16BP, is reduced 
100-fold compared to wild-type (Guo et al., 2012). QPM provides an example where the 
α-subunit expression is increased in an environment where the cell would benefit from 
increased PFP activity.   
Meanwhile, the PFP heterodimer (αβ) can be purified from tomato and remains 
active in both glucogenic and glycolytic directions (Wong et al., 1990). When purified as 
individual components, the β-subunit exhibited ~70% lower specific activity than the αβ 
heterodimer (Wong et al., 1990). The reduced activity could be an indication that both 
subunits must be present for PFP activity. To date, no in vitro analysis of the 
requirements for catalytic activity have been devised but perhaps both the α- and β- 
subunits are required for enzyme activity. Sequence alignment of the catalytic β-subunit 
of PFPs from different plants (Arabidopsis thaliana, Medicago truncalatula, Solanum 
tuberosum, and Sorghum bicolor) demonstrates high sequence conservation, 
approximately 80% identical (Figure 31).  
  99 
Arabidopsis   MAPALAVTRDLTAVGSPENAPAKGR-ASVYSEVQSSRINNTLPLPSVLK--GAFKIVEGP 57 
Medicago      MAPSFALDGGSDANRAPPPPSVTGRFASVYSEVQNSRIFHTLPLPSVLK--TPFTIIDGP 58 
Solanum       ------------------QVSGHRRYAAVYSEVQNSRLDHPLPLPSVLG--SPFKVVDGP 40 
Sorghum       MAAAAVTSNG--GAVAANGGPAPGRLASVYSEVQTNRLLHALPLPSVLR--SNFSVVDGP 56 
Entamoeba     ---------------------------MSLSALHKYRLQYKPVLPKHIADIDNITIEEGA 33 
                                            * ::. *:     **. :     :.: :*.   
 
Arabidopsis   ASSAAGNPDEIAKLFPGLYGQPSVAVVPD-QDAPSSAPKLKIGVVLSGGQAPGGHNVISG 116 
Medicago      PSSAAGNPDEIAKLFPNLFGQSSAMLVPGGSETVQLNQKLKIGVVLSGGQAPGGHNVISG 118 
Solanum       PSSAAGHPEEIAKLFPSLYGQPHVSLVPDDSGDVAMNQILKIGVVLSGGQAPGGHNVISG 100 
Sorghum       ASSAAGNPDEIAKLFPNLFGQPSASLVPA--AEPAATRPLKVGVVLSGGQAPGGHNVICG 114 
Entamoeba     KTQSAVNQKELSELFKHTYGLPICNIVAG--KNADIHRVIRCGFILSGGPAAGGHNVVAG 91 
               :.:* : .*:::**   :* .   :*.           :: *.:**** *.*****:.*   
 
Arabidopsis   LFDYLQERAKGSTFYGFKGGPAGIMKCKYVELNAEYIQPYRNQGGFDMICSGRDKIETPD 176 
Medicago      IFDYLQDRAKGSTLYGFRGGPAGIMKCKYVELTSDYIYPYRNQGGFDMIRSGRDKIETPE 178 
Solanum       IFDYLQTHCKGSTMYGFRGGPAGVMKGKYVVLTPEFIYPYRNQGGFDMICSGRDKIETPE 160 
Sorghum       IFDYLQERAKGSTMYGFKGGPAGVMKCKYVELTADFVYPYRNQGGFDMICSGRDKIETPE 174 
Entamoeba     LFDGLMKGNKENKLYGFRCGAGGILSNDYIEITAELVDKHRNTGGFDLVGSGRTKIETEE 151 
              :** *    * ..:***: *..*::. .*: :..: :  :** ****:: *** **** :   
 
Arabidopsis   QFKQAEETAKKLDLDGLVVIGGDDSNTNACLLAENFRSKNLKTRVIGCPKTIDGDLKCKE 236 
Medicago      QFKQAEETVHKLELDGLVVIGGDDSNTNACLLAEYFRSKNVKTHVIGCPKTIDGDLKCKE 238 
Solanum       QFKQAEETAKKLDLDGLVVIGGDDSNTNACLLAENFRSKNLKTRVIGCPKTIDGDLKSKE 220 
Sorghum       QFKQAEDTANKLDLDGLVVIGGDDSNTNACLLGEYFRSRNLKTRVIGCPKTIDGDLKCKE 234 
Entamoeba     QFATAFKHITALKLNAMVVVGGDDSNTNAALLAEYFAAHGSDCVFVGVPKTIDGDLKNQY 211 
              **  * .    *.*:.:**:*********.**.* * ::. .  .:* ********* :    
 
Arabidopsis   VPTSFGFDTACKIYSEMIGNVMIDARSTGKYYHFVRLMGRAASHITLECALQTHPNITII 296 
Medicago      VPTSFGFDTACKIYAEMIGNVMIDARSTGKYYHFVRLMGRAASHITLECALQTHPNITII 298 
Solanum       VPTSFGFDTACKIYAEMIGNVMIDARSTGKYYHFVRLMGRAASHITLECALQTHPNVTLI 280 
Sorghum       VPTSFGFDTACKIYSEMIGNVMTDARSTGKYYHFVRLMGRAASHITLECALQTHPNAALI 294 
Entamoeba     IETSFGFDTACKTYSELIGNIQRDAISSRKYWHFIKVMGRSASHIALEAALETQPTYCII 271 
              : ********** *:*:***:  ** *: **:**:::***:****:**.**:*:*.  :*   
 
Arabidopsis   GEEVSAQKQTLKNVTDYMVDVICKRAELGYNYGVILIPEGLIDFIPEVQELIAELNEILA 356 
Medicago      GEEVAAKKLTLKNVTDYMVDIISKRAEDNYNYGVILIPEGLIDFIPEIQHLISELNEILA 358 
Solanum       GEEVFAKKLTLKNVTDYIADVVCKRAESGYNYGVILIPEGLIDFIPEVQQLIAELNEILA 340 
Sorghum       GEEVAEKKQTLKNVTNYITDIICKRADLGYNYGVILIPEGLIDFIPEVQKLIAELNEILA 354 
Entamoeba     SEEVEDKKMTVSQIASEIADIVIERHKKGLNFGVVLIPEGLVEFIPEVKALIKELNNLLA 331 
              .***  :* *:.:::. :.*:: :* . . *:**:******::****:: ** ***::**   
 
Arabidopsis   N---------EVVDENGLWKKKLTEQSLKLFDLLPEAIQEQLMLERDPHGNVQVAKIETE 407 
Medicago      H---------ETVDEGGLWKMKLTDQSLKLFEFLPRSIQEQLMLERDPHGNVQVAKIETE 409 
Solanum       H---------DVVDEAGVWKKKLTPQCLELFELLPLAIQEQLLLERDPHGNVQVAKIETE 391 
Sorghum       H---------DVVDEAGAWKSKLQPESKELFEFLPKTIQEQLMLERDPHGNVQVAKIETE 405 
Entamoeba     HKKEEYSKITEFSAQKAFVCENISESCAATFKNLPDNIAKQLLLDRDPHGNVNVSAIETE 391 
              :         :   : .    ::  ..   *. **  * :**:*:*******:*: ****  
 
Arabidopsis   KMLIQMVETELEKRKQAGAYKGQFMGQSHFFGYEGRCGLPTNFDATYCYALGYGAGVLLN 467 
Medicago      KMFIQMVETELEKRKQEGTYKGGFKGQSHFFGYEGRCGLPTNFDSTYCYALGYGAGALLQ 469 
Solanum       KMLIQMVETELDQRKQKGAYNAQFKGQFHFFGYEGRCGLPSNFDSTYCYALGYGAGSLLQ 451 
Sorghum       KMLISMVETELEKRKAEGRYSAHFRGQAHFFGYEGRCGLPTNFDSNYCYALGYGAGALLQ 465 
Entamoeba     SFVSGIVKAEIVKR----GIKVPFTPVHHFFGYEGRCAFPSNFDSTYCYALGYTAFILLA 447 
              .:.  :*::*: :*      .  *    *********.:*:***:.******* *  **    
 
Figure 31. Alignment of 4 plant PFPs with PFP from the protist Entamoeba 
histolytica. Alignment of plant PFPs with E histolytica PFP active site residues are 
highlighted in blue, active site residues involved in PPi binding are highlighted in red, 
and additional residues involved in PPi binding are highlighted in green. The substrate-
specifying residue is in teal. 
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Arabidopsis   SGKTGLISSVGNLAAPVEEWTVGGTALTALMDVERRHGKFKPVIKKAMVELEGAPFKKFA 527 
Medicago      SGKTGLISSVGNLCAPVEEWTVGGTALTSLMDVERRHGKFKPVIKKAMVELEEAPFKKFA 529 
Solanum       SGKTGLISSVGNLAAPVEELTVGGTALTALMDVERRHGKFKPVIKKAMVELEGAPFKKFA 511 
Sorghum       SGKTGLISSVGNLAAPVQEWTVGGTALTSLMDVERRHGKFKPVIKKAMVELDAAPFKKYA 525 
Entamoeba     LKKTGQICCISGLQKPAEEWICGGVPLTIMMNMEQRNGEMKPVIKKALVEIEGKPFKFYQ 507 
                 *** *..:..*  *.:*   **..** :*::*:*:*::*******:**::  *** :    
 
Arabidopsis   SLREEWALKNRYISPGPIQFTGPG--SDSLSHTLLLELGAQ- 566 
Medicago      SLRDEWALKNCYISPGPIQFTGPG--SDAISHTLLLELGAQA 569 
Solanum       SKREEWALNNRYINPGPIQFVGPV--ANKVNHTLLLELGVDA 551 
Sorghum       SMRDEWAIKNRYISPGPIQFSGPG--SDDSNHTLMLELGAEL 565 
Entamoeba     SKRAQWASAEDFVFPGAIQYFGPSEVCDQPTKTLLLEQN--- 546 
              * * :**  : :: **.**: **   .:  .:**:** .  
 
Figure 31. Continued.  
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CHAPTER V 
CONCLUSIONS AND FUTURE DIRECTIONS 
5.1 Chapter III conclusions and future directions 
 In Chapter III, I successfully identified a second major Pdk1 phosphorylation site 
on AGC1-3, in addition to the conserved activation-loop serine. Previously an attempt to 
map Pdk1-phosphorylated residues on Adi3 with MS/MS was conducted, and although 
other residues were identified, subsequent analysis demonstrated Adi3 was still 
phosphorylated by Pdk1. With this knowledge, I explored the PhosPhAt database to see 
if any high-throughput studies identified AGC1-3 phosphorylation sites, which could 
possibly be phosphorylated by Pdk1. Within the PhosPhAt database, one of two residues 
was identified as a phosphorylated residue in AGC1-3 (Ser137 or Ser138). Around this 
same time I read a paper detailing the use of reductive mutants to study the interaction 
between AvrPtoB and Pto (Xiao et al., 2007). I determined that a similar approach could 
be used to identify AGC1-3 phosphorylation sites by making N-terminal deletions. 
These studies implicated Ser269 as a Pdk1 phosphorylation site on AGC1-3. 
Mutagenesis and MS/MS confirmed Pdk1 phosphorylates the conserved site in Adi3, 
Ser212. Subsequent studies revealed the importance of this second site in Adi3 substrate 
activation. 
5.1a Investigate AGC1-3 phosphorylation in vivo 
 Considering that Ser269 and Ser212 were both identified with recombinant 
proteins, they must be confirmed in vivo. For MS analysis of a protein, several mg are 
required, and recovering enough AGC1-3 from transient expression in protoplasts or any 
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other system could be problematic. To address problems involved with recovering 
enough protein for MS, a tandem affinity purification (TAP) plasmid was developed to 
purify protein complexes from transgenic plants (Rubio et al., 2005). The plasmid has a 
T-DNA that will overexpress a 9xMyc-6xHis fusion protein in plants and has been 
utilized to purify protein complexes as well as for post-translational modification 
analysis (Rubio et al., 2005). By using this system in transgenic plants, the tagged 
protein can be purified from the native system and will be under physiological 
conditions. Perhaps this plasmid would provide the appropriate system to recover 
enough AGC1-3 for MS analysis. If AGC1-3 could successfully be purified, a tool like 
this would enable further analysis of the AGC1-3 phosphorylation state, for example 
under different biotic and abiotic stresses. Additionally, cellular fractionation of a 
transgenic plant would enable detection of what phosphorylated species exists in 
different cellular compartments. 
 In addition to identifying a non-activation loop phosphorylation site on AGC1-3, 
I investigated if additional Pdk1 phosphorylation sites could be found in other AGC 
VIIIa kinases. I investigated AGC1-4 and AGC1-7 and found Pdk1 phosphorylates 
AGC1-7 at other residue(s) in addition to the activation loop serine. On the other hand, 
Pdk1 does not phosphorylate AGC1-4 at any other residues. Additional phosphorylation 
of AGC1-7 by Pdk1 indicates that Pdk1 does have at least one additional in vitro 
phosphorylation motif. Through a more in-depth analysis of the AGC VIIIa kinases, 
more examples of Pdk1 phosphorylation of non-activation loop residues might be 
identified. Currently three Arabidopsis AGC VIIIa kinases have been analyzed (AGC1-
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3, AGC1-4, & AGC1-7) and of those proteins, Pdk1 phosphorylates two of them at non-
activation loop residues. There is a strong chance that another Pdk1 phosphorylation 
motif or set of phosphorylation motifs exist in Arabidopsis. How common these are and 
how they alter AGC VIIIa kinase activity remains to be seen.  
5.1b Investigation of cell viability of AGC1-3 
In this study I determined that like Adi3, the NLS and phosphorylation of the 
activation loop are critical to AGC1-3’s suppression of cell death and nuclear 
localization. In order to further investigate the role of AGC1-3 as a regulator of cell 
death, I would develop transgenic Arabidopsis lines with AGC1-3 mutants under the 
control of an inducible promoter, like the hormone estradiol. With an inducible 
promoter, a number of factors can be evaluated, for instance how long after induction 
does a mutant induce cell death. Likewise mutant induced cell death can be analyzed at 
different developmental stages when protein expression is not constitutive. In studies of 
cell death induced by Adi3 and AGC1-3 mutants, viability was evaluated 24hr after 
transfection (Ek-Ramos et al., 2010). With inducible promoters, protein expression can 
be started and terminated or sustained indefinitely. Some Adi3 mutants might induce cell 
death. However it could take longer than 24 hours to develop. 
An alternative approach would be to develop an RNAi transgenic plant that 
reduces expression of AGC1-3. If a phenotype develops from transcript reduction, the 
resulting plant can be used in complementation assays with Adi3. Presumably, wild type 
Adi3 can complement the phenotype of AGC1-3, and with that, mutants of Adi3 can be 
used in additional complementation tests. Certain mutants of Adi3 would not be capable 
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of recovering the AGC1-3 RNAi phenotype, for instance the kinase inactive Adi3 would 
not be expected to recover the phenotype, nor would the activation loop extension 
mutants. It would be interesting to see if an Adi3S212D mutant could complement but 
Adi3S212D/S539D could not. Complementation of AGC1-3 knockdown phenotypes would 
allow flexibility to determine what are essential components of AGC1-3 and Adi3 for 
cell death suppression.  
5.2 Chapter IV conclusions and future directions 
 The KiC assay provided a list of potential substrates that will be useful for the 
study of AGC1-3 for years to come. A total of 37 unique proteins were implicated as 
substrates of AGC1-3 or AGC1-3S596D – previous studies have shown these proteins 
have diverse subcellular localizations and enzymatic functions. Differential subcellular 
localization of these substrates could be an indication that phosphorylation by AGC1-3 
is involved in localization. How phosphorylation by AGC1-3 impacts a given substrate’s 
activity and localization remains to be thoroughly researched. Confirmation of 
phosphorylation by AGC1-3 followed by investigation of how phosphorylation impacts 
localization and protein function will provide a greater understanding of AGC1-3’s 
function. 
5.2a Investigate phosphorylation of substrates 
 The most important thing to do with the KiC data is to verify phosphorylation of 
these full-length proteins by AGC1-3, AGC1-3S596D, or AGC1-3 activated by AtPdk1. A 
number of the substrate peptides identified in the KiC assay were phosphorylated on Tyr 
residues. AGC1-3 phosphorylation of Tyr residues was unexpected, so confirmation of 
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this function will be important to confirm or dismiss. Beyond confirming 
phosphorylation by AGC1-3, it will be important to see if the AGC1-3S269D/S596D mutant 
has higher trans-catalytic activity than the AGC1-3S596D mutant, as is the case with Adi3. 
As substrates of Adi3, it would be interesting to analyze their activity and 
phosphorylation state in the context of infection by Pseudomonas syringae pv. tomato. 
With the data from the KiC assay, I assembled a table of tomato homologues and 
indicated whether or not the phosphorylated residue is conserved. Unfortunately, there is 
not a database similar to PhosPhAt for tomato, so I cannot see if the tomato homologues 
are phosphorylated. 
5.2b Co-localization of AGC1-3 with substrates 
From my work, AGC1-3 exhibits different localization patterns – it is in the 
nucleus when phosphorylated at the activation loop serine, in spite of mutations to a 
nuclear localization signal. In contrast, AGC1-3 is absent from the nucleus when 
phosphorylation of the activation loop serine is prevented, and its nuclear localization 
signal is mutated. Based on these pieces of data, AGC1-3 changes subcellular 
localization, therefore it is conceivable that when in different places of the cell, AGC1-3 
is exposed to different substrates. One of the great advantages of working with 
Arabidopsis is the treasure trove of publicly available data in multiple different sources 
as has previously been mentioned – the PhosPhAt database, which has an overwhelming 
amount of MS protein phosphorylation data. Similar to PhosPhAt, the SubCellular 
Proteomic Database (SuBA) (http://suba.plantenergy.uwa.edu.au/) is a repository of MS 
subcellular localization data, collected from published data. Twenty of the 26 substrates 
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of AGC1-3 are supported by MS data identifying these proteins in the following 
locations: cytosol (Lee et al., 2005; Ito et al., 2011), PM (Benschop et al., 2007; Mitra et 
al., 2009; Zhang and Peck, 2011), mitochondria (Klodmann et al., 2011), extracellular 
(Bayer et al., 2006), nucleus (Calikowski et al., 2003; Tillemans et al., 2005), and plastid 
(Kleffmann et al., 2004; Ferro et al., 2010) (Table 4). Thirteen of 19 AGC1-3S596D 
substrates have MS data that implicates their subcellular localization as well (Table 5). 
The significance of this is that review of the SuBA database showed that several PM 
localized proteins were phosphorylated at the same residue(s) identified in the KiC assay 
(Benschop et al., 2007). The data from PhosPhAt and SuBA do not stand-alone. 
However, these observations present the foundation for a narrative of AGC1-3 
phosphorylation of several substrates. One potential substrate of AGC1-3S596D is 
annotated as a DHHC zinc finger protein (DZFP) (At3g48760). Previously, zinc finger 
proteins have been reported in the nucleus as well as the cytosol (Pomeranz et al., 2010). 
DZFP was also identified in a phosphoproteomic analysis of the plasma membrane and 
is phosphorylated at the same residue that was identified in the KiC assay (Benschop et 
al., 2007). Though it must be confirmed, this presents the possibility that AGC1-3 co-
localizes with and phosphorylates DZFP, perhaps to direct DZFP back to the nucleus. 
In a proteomic analysis of the plasma membrane, PFP was identified while 
another proteomic analysis identified it in the cytosol. Co-localization of AGC1-3 and 
PFP could occur at either the PM or in the cytosol. Considering that MS data support 
PFP being in different locations, it will be interesting to see if localization, 
phosphorylation, and activity can be correlated. 
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Table 4. Subcellular localization of substrates phosphorylates by AGC1-3. A X denotes MS data is available identifying 
that protein at the listed subcellular location, a X denotes MS data is available identifying the implicated AGC1-3 
phosphorylated residue is present at the listed subcellular location. 
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Table 5. Subcellular localization of AGC1-3S596D phosphorylated substrates. A X denotes MS data is available identifying 
that protein at the listed subcellular location, a X denotes MS data is available identifying the implicated AGC1-3 
phosphorylated residue is present at the listed subcellular location. 
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While characterization of PFP has commenced –phosphatidic acid phosphatase 
(PAP) is also in the initial stages of characterization. PFP was selected for more or less 
two reasons – I had never heard of pyrophosphate-dependent phosphofructokinase, I’d 
only heard of ATP-dependent phosphofructokinase and Adi3 regulates the SnRK 
complex, so there is already some precedent for AGC1-3/Adi3 to be connected to sugar 
metabolism. Phosphatidic acid phosphatase was selected for characterization because 
phosphatidic acid (PA) is a lipid singaling molecule that AtPdk1 binds via its PH domain 
– binding of PA activates AtPdk1 (Deak et al., 1999; Camehl et al., 2011). A very 
interesting scenario is presented: AGC1-3 could regulate an enzyme that controls the 
signaling molecule that indirectly regulates AGC1-3. From an anecdotal standpoint, 
characterizing PAP and the possible phosphorylation by AGC1-3 is an interesting 
project. PAP has been fairly well characterized, and in fact, phosphorylation of PAP has 
been investigated to an extent. In yeast, knockouts of the PAP homologue, Pah1p are 
highly susceptible to fatty acid-induced toxicity (Pascual and Carman, 2013). With 
respect to their phosphorylation state, dephosphorylation of Pah1p stimulates PAP 
activity (Pascual and Carman, 2013). Reviewing the list of potential substrates is a 
pleasant burden – when looking at the list of substrates, a new way to look at cell death 
regulation is considered. With that said, PFP is an interesting enzyme, with a possible 
grounding in stress response or at least in sustaining glycolysis in ATP-limiting 
environments, based on increased expression levels in QPM compared to opaque2 (Guo 
et al., 2012). 
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5.2c Utilize KiC data for studies with Adi3 
 With all of the data acquired from the KiC assay, it can be utilized for studies of 
Adi3 and AvrPto/Pto signaling. Each of the AGC1-3 substrates in Arabidopsis has a 
homologous protein in tomato, and in many cases, the phosphorylated residue(s) 
identified in the KiC assay are conserved in the tomato proteins (Table 6). Just as the 
role of phosphorylation by AGC1-3 can be characterized in Arabidopsis, study of these 
proteins in tomato will provide setting to study phosphorylation state and activity of 
proteins in response to pathogen attack. 
5.3 Final conclusions 
 In this dissertation, I present work that implicates AGC1-3 as the Arabidopsis 
thaliana homologue of the tomato cell death regulator, Adi3. I also used AGC1-3 to 
conclusively identify a second Pdk1 phosphorylation site, in addition to the AGC1-3 
activation-loop serine. This second Pdk1 phosphorylation site is conserved in Adi3 and 
was shown to contribute to substrate phosphorylation by Adi3. With the KiC assay, 37 
potential AGC1-3 substrates that comprise diverse functions were identified. The data 
acquired from the KiC assay is extremely exciting, as well – essentially every single 
peptide presents a unique project to develop. For example, prior to substrate 
identification, I was completely unaware of the enzyme pyrophosphate-dependent 
phosphofructokinase (PFP). Continuance of studies related to the KiC assay will develop 
a greater understanding of AGC1-3’s function as a cell death regulator. Future studies 
should be directed toward the implications of AGC1-3 phosphorylation of PFP, Adi3  
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Table 6. Tomato homologues of KiC assay substrates. Results from the KiC assay 
with AGC1-3 and AGC1-3S596D were used in BLASTp searches of the tomato genome. 
Of the 37 peptides, the phosphorylated residue is conserved in 26 of the tomato 
homologues. 
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phosphorylation of a PFP homologue in tomato and the implications of these events in 
response to abiotic and biotic stress. 
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